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The keto acids are those organic acids which contain a carbonyl
group in addition to that which is a component part of the carboxyl
group, i.e. R.C0.Q00H.
2. Biological Importance.
The role of keto-acids as intermediates in the metabolism of carbo¬
hydrates, fats and proteins has ensured the interest of biochemists for
many years, but the understanding of their importance in the chemistry
of pathological processes is only now becoming possible, after their
physiological importance has become more fully apparent; much still
remains to be done.
During the third decade of the 20th century, intensive work on
the aerobic catabolism of carbohydrates was undertaken by many workers,
particularly Szent-Gyorgyi (1935,1936); Stare and Baumann (1936);
Martius (1937) and Martius and Knoop (1937); their observations on the
catalytic effect of several organic acids on oxygen uptake by minced
pigeon muscle were combined with his own results by Kr.ebs in 1937, to
be amplified into the now well known tricarboxylic acid cycle, a
postulated Sequence of events occurring during the aerobic catabolism of
carbohydrate (Erebs and Johnson, 1937). Subsequent work by Khebs and
by other workers has served to confirm the essentially corredt nature of
the original concept, although important details were added in later years,
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e.g. the importance of co-enzyme A in the metabolic cycle (See Lipmann,
1954).
Further, it is now apparent that the tricarboxylic acid cycle
provides the central key to the understanding of the intermediate meta¬
bolism of many compounds including the three major groups or "proximate
constituents" of the body, i.e. carbohydrates, fats and proteins.
Figure 1 presents a scheme of the main inter-relationships of the
compounds of the tricarboxylic acid cycle and between the cycle and other
major metabolic pathways; the diagram incorporates extensions made
since Knobs' original publication in 1937.
Those compounds of immediate interest in this thesis are marked by
an asterisk.
It will be seen that pyruvate, a-ketoglutarate (now sometimes
called a-oxoglutarate), oxaloacetate and oxalosuccinate are directly
implicated in the cycle; the biological importance of these keto-(oxo-)
acids has been reviewed by Kcebs (1943) and by Ochoa (1951).
Since the citric acid cycle, is, in most cells, the main source
of the adenosine triphosphate (ATP) necessary for the synthesis of
essential cellular components including proteins, polysaccharides and
other complex molecules, it is not surprising that the enzymes of the cycle
have been found in most mammalian tissues which have been studied. It
is not proposed to discuss in detail the energy changes accompanying the
steps of the tricarboxylic acid cycle, and the reader is referred to the
review of F.E. Hunter (1951).





















Synthesis of fatty acids
Synthesis of cholesterol



























































































From /9-oxidation of fatty acids in liver
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Fig. 1. Schematic integration of carbohydrate, fat
and protein metabolism through the tricarboxylic acid
cycle (After West and Todd, 1955 )•
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2.1. Carbohydrate Metabolism.
Carbohydrate does not directly enter the citric acid cycle, but is
first broken down by glycolysis to form pyruvic acid, which then under¬
goes oxidative decarboxylation to form acetyl co-enzyme A and enters
the citric acid cycle by coupling with oxaloacetate to form citrate (Fig.
Although the glycolytic pathway produces some energy in the form of
ATP, it is less efficient than the citric acid cycle. Nevertheless,
some mammalian tissues appear to acquire most of their energy from an
active glycolytic pathway, rather than from the citric acid cycle,
which remains relatively inactive, e.g. retina, embryonic tissue, bone
marrow and brain (Warburg, 1930; Quastel, 1939).
Evidence that the citric acid cycle is concerned in carbohydrate
metabolism in invertebrates and plants has also been obtained (Rees,
1953; Vickery and Abrahams, 1949).
2.2. The Catabolism of Fats.
The preliminary steps in the catabolism of triglycerides involves
hydrolysis to form glycerol and fatty acids which are then metabolised:
a) Glycerol.
This compound is phosphorylated
0
JH20H CH-0»P-0H + ADP





and the product is reduced to dihydroxyacetone phosphate, at which stage
it enters the glycolytic pathway.
5-
Glycogen



















dehydrogenase A inhibited by iodoacetate)




















ATP - phosphoglyceric transphosphorylase
ATP
Overall reaction:
(C6H10O5) + 3 ADP +' 3 phosphate 2 lactic acid + 3 ATP + 2 H,0
Fig. 2. The glycolytic pathway (Fruton & Simmonds,
1958).
2C0Z + 2H20 202
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It is now generally accepted that the naturally occurring fatty acids
are degraded by undergoing ji-oxidation. Both saturated and unsaturated
fatty acids undergo activation, oxidation, hydration, re-oxidation and
splitting serially (see Fig. 3).
The consequence of the cleavage described above is the formation of
acetyl-co-enzyme A, which enters the tricarboxylic acid cycle.
In the case of fatty acids containing even numbers of carbon atoms,
the molecule is broken down entirely to the two carbon fragments of
acetyl-coenzyme A.
"Odd numbered" fatty acids undergo a similar process, but
propionyl - CoA, a residual three carbon fragment, is left. It is,
however, easily converted to propionic acid which readily undergoes
carboxylation to form succinic acid, the latter entering the tri¬
carboxylic acid cycle directly. (Huennekens, etal, 1951J 1953).
The metabolic changes described above usually occur in the liver,
and under normal circumstances, the "2 carbon fragments" are removed via the
citric acid cycle as rapidly as they are formed.
c) Fat metabolism in unphysiological conditions.
When the removal of acetyl-CoA is inhibited, two of its molecules
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may unite to form aceto-acetyl-CoA and aceto*acetic acid:
CH3.CO - CoA + CH3.CO - GoA + H20 j^keto- > cHyX.CH^O - CoA + CoA
thiolase aceto-acetyl CoA
CH^.CO.G^.CO - CoA + H20 deacylase ^ CH3.CO.CH2.COOH + CoA
aceto-acetic acid
Liver does not possess an aceto-acetate activating system and aceto-
acetic acid, with two of its metabolic products leak into the blood:
OH
CH3.C£.CH2.C00H ^IV-CH.CO.CH-COOH °,°2
H-OH butyric acid etic acid "^^^cetcne 3
Fig. A. The interrelationship of "ketone bodies".
There are four conditions in which ketonaemia may occur:
1) Poisoning with malonate causes a block of the citric acid cycle,
acetyl-CoA accumulates, and the formation of "ketone bodies" increases
(Geyer and. Cunningham, 1950).
2. Excess NH3 added to rat liver homogenates results in reductive
amination of«<ketoglutarate to form glutamate; the interruption of the
citric acid cycle causes a rise in "ketone body" formation due to
accumulation of acetyl-CoA (Reeknagel and Potter, 1951).
3 and 4. Starvation and diabetic crisis cause ketonaemia, andin both
appears to be due to a deficiency of oxalacetate, which is normally
provided by the carboxylation of pyruvate. In starvation, lack of
carbohydrate causes a reduction in available pyruvate, whilst impaired
glycolysis in diabetes has the same effect. Thus acetyl-CoA has an
inadequate supply of oxalacetate to condense with at its site of entry
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into the tricarboxylic acid cycle, and ketonaemia results.
The quantitatively less important source of oxalacetate - from the
deamination of aspartic acid - is not adequate to maintain normal catabolic
turnover in these conditions.
2.3 The catabolism of Amino Acids.
The lability of the amino group of the a-amino acids was demonstrated
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by Schoenheimer, who showed that N administered in the a-amino group of
15
one amino acid, or as N H.C1, could be subsequently isolated from many
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different amino acid constituents of the tissue proteins (Schoenheimer et
al, 1939).
Further, it was shown that certain indispensable amino acids (e.g.
tryptophan and histidine) could be replaced in the diet of a growing rat
by the corresponding a-keto acids. This type of work, and the number
of "substitutes" for indispensable dietary amino acids is comprehensively
reviewed by Jackson and Chandler (1939).
a-)- Oxidative Deamination. The amino acids may lose their a-NH^
group by oxidation:
^ R
H2M.Qfl. COOH + i 02 ^ 0 = C.COOH + NH^
and the presence of both a D- and an L- amino acid oxidase in rat
kidney was demonstrated by Krebs (1935). He found that the L-amino
acid oxidase activity was associated with insoluble tissue particles, from
which it could not be separated. The D-amino acid oxidase, on the other
hand, was soluble.
Blanchard et al (1944, 1945), however, isolated soluble enzyme
TABLE1.
































preparation from rat liver and kidney, which specifically oxidised L-
amino acids.
It is an interesting paradox that although D-amino acid oxidase is
widely distributed both in mammals and micro-organisms, and has a turnover
number of 2,000 as opposed to a turnover number of 6 for the mammalian
L-amino acid oxidase, no apparent physiological role for the former
enzyme has yet been found.
It is suggested by West and Todd (1955 ■•) that the D-enzyme may serve
to destroy D-amino acids produced in some metabolic process, but this
must remain conjectural, since no D-enantiomorph has been isolated from
mammalian sources.
The Aavoprotein enzymes may use molecular oxygen as the ultimate
electron acceptor (see Fruton and Simmonds, 1958).
R R
H2N-GH-C00H + flavin ^ NH = C - COOH + flavin H2
R R
HN = C-C00H + H 0 „ 0 = C - COOH + NH„
a. > 3
Flavin + 0^ ^ Flavin + H^O^
In vivo, it is probable that the widely distributed enzyme catalase,
immediately catalyses the decomposition of the hydrogen peroxide
2 H202 ^ 2 H20 ♦ 02
In vitro, however, the keto-acids produced in the above reaction
is immediately oxidised to the next lower fatty acid, unless some
substance is added which is preferentially oxidised by the hydrogen peroxide
(e.g. ethanol).
R.CO.COOH + H202 R.C00H * C02 + H20
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This observation is of considerable practical importance, for the
oxidases have been used to isolate one enantiomorph from a mixture of
both, by destroying the unwanted amino acid.
Meister (1951, 1952) has used an L-amino acid oxidase obtained
from snake venom, to prepare several a-keto-acids from the corresponding
amino acids.
The snake venom enzyme was used because its turnover number is
3,100 as apposed to 6 for the enzyme from mammalian sources.
b) Transamination. Although the amino acids may lose their a-NH2
group by enzymic oxidation, it now seems likely that dearaination occurs
in vivo predominantly as the result of the action of transaminases which
are widely distributed.
Transamination was first noticed incidentally by Herbst and Engel
(1934-) in model systems: a mixture of a-araino-phenyl acetic acid and
pyruvate heated in water, gave rise to alanine, benzaldehyde and C02,
the last two presumably derived from phenylglyoxylic acid:
' ?6h5 °h3 ch3
h2n.ch.c00h + 0 = c.coqh > °6h5 + 002 + h^.ch.cooh
a-amino-phenyl- pyruvate CHO alanine
acetic acid benzalde¬
hyde
More recently non-enzymatic transamination between glyoxylic acid
and alanine, aspartate or glutamic acid at pH 7.4- and 25-30°C has been
observed, with the production of glycine and the corresponding keto-acids
(Nakada and Wein'nouse, 1953).
cho
i -•+ ch3chnh2cooh ^ h2n.ch2.cogh + ch .co.c00h
c00h alanine ... .
glyoxylic glycine pyruvic acid
acid
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Giri (1954-) and Girl and Kalyankar (1953) noted transamination
phenomena when they studied the chromatographic separation of the free
keto-acids in tissue extracts. It appeared that the chromatographic
paper itself catalysed transfer of a-amino groups from the amino acids
present to pyruvate orWketoglutarate, when heated to 80°C, thus causing
losses of these keto-acids.
The first evidence for enzymic transamination was presented by
Braunstein and Kritzmann(1937) who showed that minced pigeon breast muscle
catalysed the transfer of the a-NH^ group of any amino acid except
glycine to«(ketoglutarate or oxalacetate, producing L-glutamic or L-
aspartic acid respectively.
Cohen later (1939,1940) showed the existence of only two trans¬
aminase systems in pig heart muscle:
1. L-glutamic acid + oxalacetic acid = a-ketoglutaric acid + L-
aspartic acid.
GLUTAMIC 0XAL0-ACETATE TRANSAMINASE ("G.O.T.")
2. L-glutamic acid + pyruvib-acid = a-ketoglutaric acid + L-alanine
GLUTAMIC PYRUVIC TRANSAMINASE ("G.P.T.")
These two enzymes appear to be ubiquitous in living organisms and
the majority of known transamination reactions involve glutamic acid as a
reactant.
Nevertheless, it is now known that G.O.T. and G.P.T. are only two of
a wide variety of transamination reactions in biological systems.
12.
Table 2. General Types of Transamination Reactions.
Type General Reaction Tissue of
origin




2 X-amino-butyric acid + a-ketoglutarate
succinic semi-aldehyde + L-glutamic acid
Brain
3 a) L-glutamine + a-keto acid a-ketoglut-
aramie acid + L-a amino acid
Liver
b) L-aspargine + a-keto acid „ . , ,*» a-ketosucc-
inic acid + L-a amino acid
Liver





a-keto-monocarboxylic acid^ + L-a amino mono-
carbosylic acid..
.
These transaminase systems have been widely studied by Meister and
reviewed by him (Meister, 1955).
The two type 1 enzymes, G.O.T. and G.P.T., are very widely distributed
in the human body, and damage to some organs, particularly heart and
liver, may cause an elevation of their activity in serum. The value of
estimating the serum G.0.T. and G.P.T. in the study of disease is well
reviewed by Wroblewski (1958).
Transaminases require pyridoxal phosphate as co-enzyme. (Fig. 5).
R1
It is postulated that the amino group donated by HOOC.&H.NHp is
transferred to the acceptor keto acid HOOC.C.11 0 via pyridoxaraine
phosphate and by a reversal of the reactions shown in Fig. 5. (Peterson









Fig. 5. Role of pyridoxine in transaminase systems
(After Fruton and Simmonds, 1958).
In vitro studies by Snell (1945) suggest that the reactions of
figure 5 are freely reversible , so that it is easy to see how the a
amino group from one amino acid may be utilised to synthesise another








































The particular importance of glutamic and aspartic acids in nitrogen
transfer is in agreement with the observations that they take up N"^
administered to rats as labelled amino acids more rapidly than any of the
other tissue amino acids (Schoenheimer et al, 1939).
Apart from the preliminary deamination which is common to all
a-amino acids, each one has its own particular catabolic pathway, some
of which are complex.
However, degradation eventually gives rise to a compound related
to the substrates of the citric acid cycle, and their relationship to
this cycle are summarised in Figure 1.
3. Keto-acids isolated from mammalian sources.
Althouth it is evident from the above discussion that many kete-
acids of great physiological significance exist, relatively few have
been isolated from mammalian blood and urine.
By contrast, numerous keto-acids, many of obscure significance,
have been isolated from plants. (Towers r Virtanen
et al, 195-4, 1955).
3.1 a-Keto-acids.
These compounds are presented below in tabular
arrangement.
15.




Pyruvic p., ch3co.cooh Blood, urine,
g.s.f.
a-keto-glutaric kg hooc.co.(ch2)2cooh Blood, urine,
C.s.f.
a-keto-isovaleric kiv (ch3)2.ch.co.gooh Blood. Urine„»nly
in "Maple Syrup"
Disease
a» keto-isocaproic kig (CH3)2CH.CH2.C0.C00H as KIV
a-keto"3-methyl-iso-
valeric
kmv ch3.gh2.CH( CH3) co. cgoh as KIV
















OA and OS have not been isolated from mammalian blood, although Frohman,
Orten and Smith (1951) claimed to have isolated OA from rat blood (<0.1 mg/
100 ml.). Their experimental method has been severely criticised by
several workers (see Neish, 1957) and no one appears to have substantiated
their claim.
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The elusive nature of OA and OS is probably explained by the
observations of Irebs (1942) and later by Ochoa (1948).
Krebs found that the compounds underwent spontaneous decarboxylation
in pure aqueous solution, and that decomposition was accelerated by
trace amounts of some amines (e.g. co-carboxylase) and of the polyvalent
++ ++ ++ ++ +++ ++ ++ ++
cations Co , Zn , Gu , Fe and Fa , although Ca , Ba , Mg and
Mn++ were relatively ineffective.





CH0 CO + C0„















Half life: 25 min. (pH 5.1, 25°G().
Ostern (1933) and Bessmann and Layne (1950) found that amino acids
also catalysed the decomposition of OA and OS.
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Aceto-acetic acid is less unstable than OA and OS, but it will















4. Properties of the keto-acids.
She presence of the carbonyl group endows keto-acids with two
important properties.
4.1 Strength of the acids
By comparison with the corresponding alphatic acids, the keto-acids







(After Fieser and Fieser,1950)
and the published pK values for various acids may be compared:
18.






Aceto- CH .CO.CH COOH 3.58
acetic
Oxalo- COOH.CO.CHpCOOH pKl 2.56
acetic pK2 4.37







(Long, King andSperry, 1961).
It will be noted that the closer the proximity of the carbonyl group
to the carboxyl group, the greater is the strength of the acid. The
influence of the carbonyl group and of its position on strength is reviewed
by Edsall and tfyman (1958).
4.2 Enhanced reactivity.
The presence of the carbonyl group results in much greater reactivity
than is found in the corresponding saturated fatty acidj indeed as is
seen above, those keto-acids with the carbonyl group lying in a p-position
with respect to the carboxyl group decompose spontaneously.
In addition to possessing the general features of organic acids,
the keto acids react readily with "ketone reagents", and the carbonyl
group is readily oxidised or reduced.
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Unfortunately these reactions are common to all keto-acids, and
though they have been made use of to estimate individual keto-acids,
it has, so far, been impossible to separate and identify mixtures of
them by purely chemical means.
Many of the methods described below are now obsolete since recent
developments,particularly in chromatography, have made it possible to
achieve separation and estimation with ease and specificity. However,
a few of the older methods have been resuscitated and successfully
employed in the solution of specific experimental problems.
4.2.1. Addition of sodium bisulphite.K
QH




Binding of NaHSO^ with ketones was first introduced by Ripper (1900)
to estimate acetaldehyde, but it was subsequently developed for the
estimation of any keto-acid (Cook, 1930; Clift and Cook, 1932).
Various authors, however, appear to have found the method
unreliable, and it fell into disrepute for the analysis of tissue keto-
acids (Long, 1942). Nevertheless, the method has been used success¬
fully to trap and separate a-keto acids from radioactive acetate in
metabolic studies using tissue extracts (Evarame and Hellman, 1954).
4.2.2. Oxidation.
Quantitative conversion to the next lower fatty acid occurs
readily and Krabs (1938) successfully exploited this property in tissue
studies, measuring the GO^ evolved manometrically:
R.CO. COOH + (0) = R.C00H + C02
20.
Suitable oxidising agents are KMnO^ (Kfeebs, 1938; Krebs and
Eggleston, 194-8; Green, Leloir and Nocito, 1945), or eerie sulphate
(Meister, 1952; Fromageot and Desnuele, 1935). Unfortunately, not only
does this method estimate all the keto-acids in a tissue extract, but
lactate is also oxidised to acetaldehyde, with the production of GO^J-
CH_CH0H.C00H. + (0) = CH-CHO + C0o + Ho03 3 <■ <■
(Gordon and Quastel, 1939).
4.2.3. Reduction.
This also readily occurs, to form the corresponding hydroxy-
acid and Friedemann, Cotonio and Shaffer (1927) estimated pyruvate by
reducing it to lactate and oxidising the latter to acetaldehyde which
was then trapped in sodium bisulphite.
CELG0.C00H + -21(H) Zn - 0^ > CH,CH0H.C00H3 couple 3/
KMn04
(0)
CH3.CH0 + H20 + C02
4.2.4. Condensation Reactions.
Various condensations, notably with various derivatives of











C = 0 + H>N.NH.CO.NH = c = N.NHGO. NH,
i H .
COOH GOOH
The reaction with semicarbazide has been used to estimate keto-
acids (Wendel, 1932) and for the isolation of a-keto-glutarate* from
kidney homogenates in metabolic studies (Buchanan et al, 1945). The
compound has been used as a locating agent when chromatography of free
keto-acids has been undertaken, the condensation product being opaque to
ultraviolet light (Magasanik and Umbarger, 1950 j Umbarger and
Majasanik, 1952).
4.2.4.3. Hydrazine.
The most successful methods of analysis of the keto-acids is
based upon the^bservations of Maclean and of Dakin and Dudley in 1913 that
the keto-acids formed hydrazones with hydrazine and with 4-nitrophenyl-
hydrazine. The former is subject to the objection that double
condensation occurs:
R1 R11-1- 1
0 = 0 + jj>N. nh2 > C = n-wH2 + H20
COOH GOOH
?1 ?2 ?1 ?2
G = N.N<? + 0 = G c=W.N = C
1 ' ^ 1
COOH COOH cooH C00H
22.
and for this reason Dakin and Dudley introduced the use of the nitro-
phenyl derivative. Further study led Case (1932) to propose the use
of 2,4 dinitrophenyl-hydrazine (2,4-D.N.P.H.) since he found that this
compound coupled with keto-acids more quickly than any other phenyl-
hydrazine derivative..
Case's reagent also had the advantage that the condensation product
had an intense yellow colour which became an intense red colour (Max^
absorption at approximately 440 my, ) on adding sodium hydroxide. These
properties permitted the measurement of very small quantities of keto-
acids.
Fig. 6. 2.4-dinitrophenyl-hydrazine.
The use of 2,4-D.N.P.H., however, is open to two major objections:
1) The reagent is non-specific, reacting with any ketone.
2) The method does not differentiate between a-and p-keto-acids (Barren-
scheen and Dregus, 1931).
The method of Case and its subsequent modifications (Peters and
Thompson, 1934} bu> 1939; Beuding and Wortis, 1940), attempted to
separate the "neutral" and "acidic" hydrazones by partitioning these
23.
compounds between ethyl acetate (containing the non-acidic compounds) and
a weak alkali (usually 10# Na^CO^ solution) which held the acidic compounds.
This method was fairly successful in achieving this aim, but suffered
the disadvantage that all keto-acids were quoted as "pyruvate", although,
as will be shown below, some of the keto acid present was in the form of
a-ketoglutarate. Further, although little the p-keto-acid,aceto-acetic
normally passed into the alkaline layer, sufficient could be extracted
into the latter to cause abnormally high levels of "pyruvate" when subjects
were ketonaemic.
The first step towards a specific method was made by Friedemann and
Haugen in 1943. They found that keeping samples of blood, precipitated
with trichloracetic acid/overnight in the refrigerator allowed the
aceto-acetic acid to decarboxylate spontaneously to acetone, which was
not extracted into the 10# Na^CO^.
These authors also noted that the hydrocarbons xylene, toluene or
benzene extracted different keto-acid hydrazones to degrees which
differed from those of ethyl acetate#:
Solvent Percentage of known K.A. hydrazone content extracted
into solvent.
Pyruvate a•Ketoglutarate. .
Ethyl acetate 81 79
Toluene 93 29
Thus by using toluene or the other hydrocarbons, specificity was enhanced
considerably. Studies of the reaction times between 2,4-D.N.P.H. and
pyruvic and a—ketoglutaric acids showed that the former reaction was
completed in 5 minutes, the latter requiring 25 minutes.
Based on these observations, two extraction procedures were
evolved:
Procedure A Procedure B
Incubation of reaction mixture 25 rain 5 rain
at 25°C.
Extractionj volume and solvent 8 ml. ethyl 3 ml. xylene, toluene
or benzeneacetate
Re-extraction with 10% NaJXL
Alkali added to 5.0 ml. of
Na^jCO^extract
6 ml.
5.0 ml. x 1.5 N
Na OH
6 ml.








Pure solutions of pyruvic and a-ketoglutaric acids subjected to
procedure A were found to possess slightly different light absorption
curves, when examined with the Evelyn colorimeter, and the authors
exploited these differences to calculate the approximate concentration
of each of the keto-acids.
After applying the methods outlined above, Friedemann and Haugen-
drew the conclusion that some 10-20% of the total keto-acid content of
the blood was a-ketoglutarate.
Truly specific methods for the separation of mixtures of ketoacids
or their derivations did not become available until the introduction of
partition chromatography by Martin (Martin and Synge, 1941; Consden,
Gordon and Martin, 1944).
25.
5. Paper Chromatography of Keto-acids♦
5.1. The Hydrazones.
Separation of the 2,4-dinitrophenyl-hydrazones of keto-acids by-
paper chromatography was introduced by Cavallini, Frontali and Toschi
(1949a, 1949b) and subsequently modified by various workers (Kulonen et
al, 1952; El Hawary and Thompson, 1953; Gey, 1954; McArdle, 1957).
All these methods were essentially similar; reaction mixtures of
2,4-D.N.P.H. and protein free supernatants were extracted after the
method of Friedemann and Haugen (1943) using ethyl acetate and 10% Wa^-
GO^. The Na^CO^ extract was acidified with concentrated HC1 and re-
extracted into ethyl acetate, which was then evaporated to dryness. The
residue was taken up in buffer, pH 7.2,and spotted onto the chromato¬
graphy paper.
These authors identifiedVketoglutarate and pyruvate whilst some
thought that substantial quantities of aceto-acetate were present in
normal blood (e.g. El Hawary and Thompson, 1953). In fact, this last
observation was an artefact and due to the authors being unaware that
pyruvate produces two hydrazone spots on chromatography and that one of
the pyruvate spots had the same Rf as aceto-acetic hydrazone in some
solvent systems (Kulonen, Carpen and Ruikolainen, 1952; El Hawary and
Thompson, 1953,1954),but not apparently in others (Markees and Gey, 1953;
Markees, 1954)•
Isomerisation of the keto-acid hydrazones is reviewed below.
Friedemann and Haugen (1943) noted that diethyl ether extracted
more of the hydrazones from aqueous solutions than did ethyl acetate,
26.
and Meister (1951) and Metzler and Snell (1952b) pointed out that 10%
Na^CO^ did not extract all keto-acid hydrazones from ethyl acetate, citing
the example of KMV-hydrazone,which is almost entirely retained in the ^£00^
solution.
In 1954, Cavallini and Frontali suggested that ether be used as the
extracting solvent, and that the dry residue obtained by evaporating this
-solution be partitioned between chloroform and I.O.N. NH.OH solution.
4
The adoption of this method was quickly followed by the identification
of a-keto-isocaproic acid in blood (Biserte, Osteux and Dassonville, 1955),
though Turnock (1953) had previously wrongly identified the compound
as phenyl-pyruvic acid.
De Schepper, Parmentier and Van der Haeghe(l958) using a similar
technique, first identified the three "branch chain" keto-acids (KIV,
KIG and KMV) in blood extracts. The hydrazones of these three compounds
ran together in a composite spot, and could not be separated by simple
modifications of the solvent systems used; the presence of the individual
hydrazones within the spot was confirmed by catalytic hydrogenation.
5.2 Identification of the hydrazones of keto acids.
Catalytic hydrogenation of keto-acid hydrazones was first demonstrated
by Fisher and Groh (1911). though Towers et al (19549 J 1954b) carried out
more detailed studies. The method has been reviewed by Smith (i960) and
is generally regarded as a most useful means of identification.
Unfortunately there are three defects;
1) A few hydrazones give rise to trace amounts of amino acids other
than that corresponding to the keto-acid of origin. Thus Towers et al
(1954a) found that reduction of«.ketoglutaric hydrazone gave rise to
glutamic acid, and also to minute amounts of Y-amino butyric acid,
27.
thought to be derived from thec^ketoglutarate hydrazone by decarboxylation.
2) Quantitative conversion does not occur. Thus, if a keto-acid
produces two spots on chromatography (e.g.. P and KIC), only one will
reduce to the corresponding amino acid.
3) Reduction of a contaminant commonly present in dinitrophenyl-
hydrazine solutions produce a ninhydrin positive spot. The contaminant
is thought to be l-hydroxy-6-nitro-ly2,3 benzotriazole. (Towers and
Mortimer, 1954} Brady and Day, 1923).
5.3. Disadvantages of chromatography of hydrazones.
Although much information about the keto-acids has been obtained
by the chromatography of their hydrazones, two major defects are inherent
in the methodt
l) Formation of Isomers.
Le Page (1950) first noted the formation of two hands from pyruvate
hydrazones during column chromatography, and his observations were
extended by many other workers:
Authors Keto-acids-producing two spots
Le Page (19$0) ) Pyruvate
Seligson & Shapiro (1952)
Markees & Gey (1953)
Altmann et al (1951)
Kulonen et al (1952)
Tufinock (1953)
Metzler, et al (1954) Ketoisocapfoatej p-hydroxy phenyl-pyruvate
Both Le Page and Metzler and Snell (1952a) reported that fresh ethyl
acetate solutions of pyruvic hydrazone gave one spot on chromatography,




Cavallini and Frontali (1954) found that synthetic pyruvic hydra-
zone spotted onto the paper direct and subjected to chromatography pro¬
duced one spot, but the same keto-acid subjected to their reaction and
extraction procedure produced two spots on chromatography.
Metzlar and Snell (1952a) and Cavallini and Frontali (1954)
reported that the slower of the two spots, when obtained, possessed the
same Rf value as the one spot obtained from the chromatography of the
fresh synthetic hydrazone.
Markees and Gey (1953) studied the two spots from pyruvate hydrazone
in more detail:
Hydrazone Rf* max.mu, M.Pj(°C)
"A" 0.36 355 210-211 (sharp)
"B" 0.57 375 Sintered 160,melted 190
* The solvent system used was n-Butanol: 3% NH.OH = 95 J5.
4
Compound "B" was found to be unstable, forming a mixture of
*A" and "B" on standing.
Compound *A" showed the elemental analysis which was anticipated,
but,of compound'b" the authors state "Extensive efforts to identify its
chemical nature were unsuccessful, and the question of possible isomery,
tautomery or transformation into closely associated product must remain
open.11
Isherwood and Jones (1955), after surveying the physical properties
and infra red spectra of the two spots obtained, suggested, that isomer-
isation occurred around the -0= N- bond: (Fig. 7)
McArdle (1957) found that the faster spot was slow to develop the
usual pink colour on adding NaOH.
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Fig. 8. l-hydroxy-6nitro,-1-2-3 benzotriazole.
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Because of the formation of such isomers, two dimensional
chromatography is impracticable, for each spot divides yet again when
a second solvent is used, so that four- spots would be formed from each
compound capable of isomerisation.
Towers and Mortimer (1954) noted a yellow spot running in close
association with one of the pyruvate isomers, and it was found to be
l-hydroxy,-6 nitr0,-1,-2,-3 - benzotriazole, first synthesised by
Brady and Day £1923). (Fig. 8)
It is thought that the compound arises from the action of alkalis
on dinitrophenyl-hydrazine j fortunately it remains yellow when NaOH is
added, and does not seriously interfere with the colorimeteric estimations
of keto-acid hydrazones in alkalis.
5.4-. Formation of Nitroquinoxalinols.
In order to avoid the problem of isomerisation of the hydrazones,
the use of/l:2 diamino-4*nitrobenzene was introduced (Hockenhull and
Floodgate, 1952, Zamboni and Defrancheschi, 1954> Smith and Taylor,
1953J Taylor and Smith, 1955). The compound couples with the keto-
acids to produce a yellow derivative, and has the additional advantage
of being specific for a-keto-acids, since it does not react with acetone
and powerfully catalyses the decarboxylation of B-keto-acids (Edson,
1935). The normal range of keto-acid concentrations in blood is
substantially lower than that obtained using 2,4 D.N.P.H., perhaps due
to the fact that a solution of the diamino-nitrobenzene reagent
autoxidises on standing, to produce a phenazine derivative which rapidly
decarboxylates a-keto-acids.
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A further disadvantage is that the method is lengthy, requiring
a 12-16 hour reaction time, instead of the 30 min. required by the 2,4-
D.N.P.H. method.
5«5. Chromatography of Free Keto-Acids.
Chromatography of free keto-acids has been undertaken (Lugg and
Overell, 194-9; Wieland and Fischer, 1949; Norris and Campbell, 1949;
Magasanik and Umbarger, 1950), but the method has not found much favourj
experimental conditions are extremely critical, the method is laborious,
requiring the use of a locating agent on the developed chromatogram,
and only large quantities of keto-acids can be detected. Further, the
free keto-acids are relatively unstable. The method appears to be
suitable for the analysis of simple mixtures, rather than of the complex
mixtures obtained from plant and mammalian sources. (Magasanik and
Umbarger, 1950).
6. Column Chromatography.
A few workers have used column chromatography:
Authors State of keto-acids Nature of column
Frohman, Orten & Smith (1951) Free Silica gel
Le Page (1952) hydrazone diatomaceous earth
Datta et al (1950) hydrazone alumina
Drew et al (1953) hydrazone cellulose powder
These methods are much more tedious than is paper chromatography, and
cannot be applied to the analysis of micro quantities. For these reasons
most workers have preferred paper chromatography.
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7. Miscellaneous Methods of Estimation.
Many specific methods for the estimation of single keto-acids have
been introduced, but have rarely been used by any except their
originators. They are reviewed by Neish (1957).
Electrophoresis is not a successful analytic tool (Neish, 1953af 1953b)
7.1. Enzymatic Methods.
Those with experience of chromatography of keto-acids agree that
the method is tedious (Marks, 1961), and in circumstances when only one
keto-acid is of interest, a rapid, specific method would be preferable.
This need has been partially fulfilled by the introduction of specific
enzymatic methods for pyruvate and a-ketoglutarate.
Both are dependent upon the fact that reduced DPN (i.e. DPNHj.H )
shows an intense absorption band at 34-0 mu, not possessed by DPN. It is
thus possible to follow the course of any reaction which requires the
co-enzyme, by using ultraviolet spectrophotometry.
7.1.1. Lactic Dehydrogenase. (Kubowitz and O.tt,1943).
2 CH„C0. G00H + DPN5.fi+ -LiElS* 2 CHJ3H0H.C00H + DPN+
Ochoa et al (194-8) believe that LDB is specific but Meister (1950)
and Meister and Tice (1950) showed that ketobutyric, hydroxypjtruvate,
glyoxal and certain ay if-diketo-acids also acted as hydrogen acceptors
though the turnover rates were relatively minute. The method has been












<-Ketoglutarate has been estimated with the enzyme by Seitz, et al
it
(1955); Klingmuller and Vogelsang, (1955); Englhardt-Goelkel et al,
(1955); Henley and Pollard,(1955);&Marks, (1961).
Kits of reagents using these enzymes are now available commercially.
7.1,3. Miscellaneous Enzymatic Methods♦
least carboxylase is a nonr-specific enzyme, but, nevertheless,
was used by Westerkamp (1933) for the estimation of serum "pyruvate"
content.
CH^CO .COOH ^ CH^CHO + C02
The evolved CO^ was measured manometrically, but the enzyme also
decarboxylates OA, KIV, KIC and KMV (Meister, 1951).
8. Concentration of keto-acids in human blood.
8.1. Normal subjects.
Before discussing the levels of keto-acids found in normal blood,
it is important to consider the methods of collecting specimens.
It has been shown that pyruvate is lost if blood is kept for a few
minutes after withdrawal (Bending and Wortis, 1940). In order to
prevent this change, most workers carry out deproteinisation at the bed








claims that a mixture of cetyl trimethyl ammonium bromide and citrate
buffer "stabilise" the blood for a period of several days. Few workers
appear to have used Long's method.
Further, severe muscular exercise causes a rise in the pyruvate
concentration of venous blood. {Johnson and Edwards, 1937} Lu and Piatt,
1939} Friedemann and Barborka, 1941} El Hawary and Thompson, 1953).
On the other hand, moderate activity such as laboratory work does
not influence the pyruvate level (Friedemann, Haugen and Kmieciak, 1945).
Lip service has been paid by many to the necessity for avoiding
venous stasis and hand clenching when collecting blood samples, but most
workers appear to agree that moderate stasis and hand clenching have no
effect on the pyruvate concentration in venous blood (e.g. Segal, Blair
and Wynngaarden, 1956).
Ingestion of food is followed by a rise in blood "pyruvate"
(Friedemann, Haugen and Kmieciak, 1945} Amatuzio, Shrifter, Stutzman
and Nesbitt, 1952). Friedemann and Haugen (1943) report two subjects
in whom the ingestion of an unstated quantity of glucose caused the
blood pyruvate level to rise to 161$ and 198$ of the fasting level,
2 hours after administsation of the carbohydrate:..
In order to avoid false levels of keto-acids it is customary to
take four precautions:
1) The patient is fasting or should have ingested nothing for 4 hours.
2) The patient should pest for at least jr an hour before collection.
3) Despite the observations made above, attempts are made to minimise
venous stasis during collection.
4) The blood is immediately deproteinised.
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Despite these precautions, several workers, including the present
author, have noted changes in the blood pyruvate concentration over short
periods of time. Thus Segal, BJair-andi '.iyn^aarcLen(1956) noted a
falling concentration of pyruvate during hourly sampling throughout
the morning, in each of two fasting subjects. The minimal levels reached
were 10% and 13% of the respective fasting levels.
They also found considerable variations in any one subject, both
from day to day and throughout any one day.
Blood concentration of the keto-acids in resting and fasting or post
absorptive subjects, found by various workers, are presented in Table 5.
Several features of the table are of interest.
In those investigations where chromatographic methods were used
in parallel with the Friedemann and Haugen method, and Miere the same
initial extraction procedure was used in both, the total keto-acid
content measured by the Friedemann and Haugen procedure was greater than
the sum of the individual keto acid contents measured by chromatography.
(Concentration of all keto-acids being quoted as '"pyruvate").
These differences were noted by Cavallini and Frontali (1949a);
El Hawary and Thompson (1953) and Bianchessi (1958).
It has been customary to ascribe these differences to the more
lengthy procedures involved in chromatography, but it must be noted that
McArdle (1957) presented the results of 100 parallel estimations in which

















Hennes et al 8
'(1957)
McArdle (1957) 8
Biserte et al KG15
; (1958) P. 28
De Schepper ?75
et al(1953)
Smith & Taylor 7
i (1955)
Segal et al 14
(1956)
Hess (1955) NQ




















































































































Total hydrazones 1.29 mg/
100 ml. (mean value).
"Pyruvate" is total keto-
acids as estim. by Friede¬
mann & Haugen technique.
Same comment as a-bove. Few
details in paoer.
Total hydrazones by F & H
method on same blood specs.
= 0.88Kmg/l00 ml. (mean value-
Total hydrazones by F & H
= 0.87smg/100 ml. (mean Aalue)
Comparison of own method
with that of F & H below
Number subjects and means
not quoted.
Table5. Blood concentration of keto-acids in normal subjects.
The key to the table is to be seen behind it.
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KEY TO TABLE S
N.Q. = not quoted,
it = as pyruvate.
glut, dehydrog. = glutamic dehydrogenase.
L.D.H. = Lactic dehydrogenase.
lood concentration of keto-acids in normal subjects.
The key to the table is to he seen behind it.
36.
















It will also be noted that the ranges quoted for the various keto-
acids vary from author to author, even when the same method has been used.
It is suggested that there are three possible causes for these
variations.
1. Small samples. Most workers have studied small numbers of subjects,
so that sampling error may be a large factor in the noted variations from
author to author.
2. Variation in the state of the subject. It has been noted that
activity, ingestion of food, fasting, marked venous stasis and emotional
disturbance may cause the pyruvate concentrations to vary. Further,
spontaneous variations in pyruvate concentration have been noted to occur
in any one subject under constant conditions. It is evident that small
variations in the techniques of sampling blood or preparing the subject
may cause considerable variation in the results obtained by different
workers.
Most of this work, of course, has been directed towards the study of
pyruvate alone, either "true" or "total" level being quoted in the
literature. "True"1 pyruvate implies specific estimates of pyruvate
by either chromatographic or enzymatic methods, whilst "total" implies
the results obtained by procedure A of the Friedemann and Haugen technique
(see above j page 24).
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3. Accuracy of the methods used. The reliability of the methods used
by some workers must remain in doubt, for reproducibility and recovery
of added keto-acids are not quoted, (e.g. Hennemar/and Bunker, 1957;
Kerppola, 1953).
8.2 Aceto-acetic acid.
Non-chromatographic methods for measuring blood aceto-acetic acid
levels have, with one exception, been non-specific, estimating the
"ketone bodies" together (i.e. acetone plus aceto-acetate plus p-hydroxy-
butyric acid).
All published methods are based upon the principle that aceto-acetic
acid is hydrolysed to acetone by boiling with acid and that p-hydroxy-
butyric acid can be oxidised to acetone; acetone and aceto-acetic acid
are estimated together, after which the -hydroxy-butyric is oxidised to
acetone and estimated. The acetone resulting from these procedures has
been estimated by numerous methods, but the most successful have been to
couple it with 2,4- D.N.P.H. (Greenberg and Lester, 1944; Mayes and
Robson, 1957; Werk et al, 1955) or with salicylaldehyde (Bakker and White,
1956-57; Thin and Robertson, 1952) and to estimate the product formed
colorimetrically.
Thus aceto-acetic acid is usually estimated by difference:
e.g. Aceto-acetic acid = (Acetone + Aceto-acetic acid) - acetone.
or Aceto-acetic acid = Total ketone bodies - (acetone + p hydroxy-
butyric acid)
and a true estimate of the aceto-acetic acid content is difficult to
obtain; for this reason most authors have preferred to quote the "total
ketone body" content of blood (ranging from 0.3 to 1.0 mg/100 ml in normal
blood, expressed as acetone).
38.
However, Rosenthal (1949) introduced 4-nitrobenzene diazonium salt
as an analytical reagent, the condensation product being measured color-
imetrically. This reagent does not react with p-hydroxy-butyrate nor
with acetone, but the specificity is of a relatively low order since
oxalacetate, pyruvate, tyrosine and thymine all produce coloured
complexes, although tbe. molar extinction coefficient of these
compounds is considerably lower than that of the aceto-acetate nitrobenzene
diazonium complex. In addition Rosenthal found that the aceto-acetate
present in protein free filtrates of blood could be easily destroyed by
heating in boiling water for 5 minutes, after adding l/lO volume of
5.0 N.H^SO^. He found that pyruvic acid was unaffected by this
treatment, and thus aceto-acetic acid was measured by the difference
between treated and untreated filtrate.
Rosenthal found a range of 0.095 to 0.26 mg/100 ml. for the blood
aceto-acetate concentration in 5 normal subjects.
Thus there is evidence to suggest that aceto-acetic acid is present
in normal human blood, although confirmation of the concentrations found
by Rosenthal does not appear to have been made.
With these observations in mind, it would seem curious that aceto-
acetic acid has been rarely seen in chromatograms of the keto-acid
hydrazones. The instability of free aceto-acetic acid, however, has
already been noted, and it is probable that the hydrazone of the
compound also undergoes decarboxylation during the lengthy extraction
procedures, so that the resulting acetone hydrazone is not being
extracted into the final alkaline solution. But in conditions where
aceto-acetic acid concentrations are high (e.g. in diabetic ketosis),
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some of the compound persists until the chromatography step.
El Hawary and Thompson (1953) present evidence for the decarboxy¬
lation of aceto-acetic acid during extraction.
9. Urinary Keto-Acids.
Studies on urinary keto-acids have been few, although observations
are reported by Biserte and Dassonville (1956), McArdle (1957) and
Marks (1961). McArdle noted that the rate of excretion in females is
approximately twice that in males, and that it varies with the menstrual
cycle, being maximum 2-3 days before menstruation.
Other evidence of the presumed effect of female sex hormones on
acids of the citric acid cycle has been presented by Shorr, Bernheim and
Taussky (1942) who demonstrated cyclical variations in citrate excretion,
the levels being maximal in the middle of the cycle and immediately
before the onset of menstruation. The injection of oestradiol into
women with amenorrhea increased citrate excretion, although plasma
citrate levels remained constant.
In both sexes, theo<(ketoglutarate concentration in urine is greatly
in excess of that of pyruvate, the reverse of the situation in blood.
Circumstantial evidence exists to suggest that urinary a-keto-
glutarate is produced by the kidney cells themselves, in addition to any
which may be present in the glomerular filtrate (Krebs, Salvin and
Johnson, 1938; Orten and Smith, 1937; Milne, Scribner and Crawford, 1958)
It appears that a-ketoglutarate excretion is related to the state
of acid - base balance, for the urinary level in respiratory (but not
metabolic) alkalosis increases despite constant blood concentrations;
the rise however, is quantitatively small by comparison with the
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rise in citrate excretion (Evans, McIntyre,Macpherson and Milne, 1957).
It has been suggested that this change in a-ketoglutarate excretion
assists renal compensatory mechanisms in respiratory alkalosis. When
human subjects are subjected to prolonged hyperventilation, serum
"" +
chloride rises whilst HCO^ and Na fall, and it is suggested that an
increased excretion of oketoglutarate and citrate ions conserves the
CI which is to be returned to the blood by the kidjieys (Cooke et al, 1954;
Brown, 1953).
tf-Ketoglutarate and pyruvate are the only keto-acids found in
measurable quantities in urine, though minute unidentified traces of
others have been found occasionally (Biserte and Dassonville, 1956;
McArdle, 1957).
10. Keto-acids in Disease.
10.1. Disorders of carbohydrate Metabolism.
10.1,1. Beriberi.
Blood pyruvate concentrations have been used for many years as
an index of changes in carbohydrate metabolism, and one of the first to
utilise this parameter was Peters, who showed that rats deficient in
thiamine had a high blood pyruvate level (Peters and Thompson, 1934$
Thompson and Johnson, 1935; Peters, 1936).
Peters suggested that thiamine was essential as a coenzyme in
the pyruvic oxidase system. (Fig. 9).
Soon after this, Piatt and Lu (1939) showed that the blood
pyruvate concentration was raised in acute beriberi, although later
workers found that the blood pyruvate level was not often raised in
-a.
fasting patients with subacute or chronic beriberi. Administration of
glucose to the latter patients did, however, cause a more marked and
prolonged rise of the blood pyruvate level than in normal subjects. This
test is considered to be more reliable than the simple estimation of
fasting blood pyruvate level, in the diagnosis of thiamine deficiency.
(Bending, Stein and Wortis, 1941J Elsom, Lukens, Montgomery and Jones,




















Fig. 9 The pyruvic oxidase system (after Fruton
and Simmonds, 1958).
Arsenic, gold, mercury and antimony have been shown to react with
the thiol groups of proteins (Thompson and Whittaker, 1947)«
Combining this observation with the close similarity in the
clinical features of beriberi neuropathy and arsenical poisoning,
Joiner, McArdle and Thompson (1950) were led to investigate the effect
of thiamine on patients with neuropathy of no known aetiology.
4-2.
The patients were given glucose, and those showing an exaggerated
blood pyruvate rise were treated with massive doses of thiamine, the test
being repeated after this. If the patient showed no change in his
response to glucose, he was given dimercaprol (BAL) on the assumption
that some heavy metal was responsible for the neuropathy. The results
were disappointing.
"Epidemic dropsy" occurred in widely scattered districts of
India, and intensive epidemiological study of the disease (Lai et al,
1939; 194-0; 1941) led to the conclusion that the victims had ingested
mustard seed oil contaminated with oil expressed from the seeds of the
plant argemone mexicana. Subsequently Sarkar (194-3) isolated the toxic
alkaloid sanguinarine, which he showed, by in vitro studies,to inhibit
the pyruvic oxidase system and to cause a rise in the concentration of
pyruvate in rat blood. This finding agrees with the observations of
Wilson and Ghosh (1937) that the bisulphite binding capacity of the
blood rose in cases of epidemic dropsy, although no one appears to have
measured the pyruvate concentration in this condition.
Sarkar (194-8) drew the conclusion that interaction between the
occurs,
alkaloid and the -SH groups of pyruvic oxidase/to inactivate the enzyme.
10.1.2. Diabetes Mellitus.
In view of the widespread nature of the disease, it is not
surprising that much work has been undertaken in an attempt to obtain
an understanding of the biochemical lesions responsible for diabetes
mellitus.
Unfortunately, as in many other fields in which keto-acids
have been studied, the results have been conflicting, some authors finding
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high values, others normal, e.g.
Author Findings (Blood)
V-Ketoglutarate and pyruvate raised
in fasting diabetics.
Villano (1952) )
Seligson & Shapiro (1952) )
Bending, Wortis, Stern & )
Esturonne, (1942) )
Klein (1942) )
pyruvate normal in fasting
diabetics.
Lestradet and Guest (1951) )
Von Marken Lichtenbildt and )
Florij.n (195 2(1955) )
Normal blood pyruvate in diabetic
ketosis.
Similarly, the response to administered glucose was found to vary.
Many have reported no rise in blood pyruvate, though all normal subjects
showed a rise after glucose administration (Klein, 1942; Beuding, Wortis
Fein and Esturonne, 1942; Miller et al 1952; Himwich and Himwich, 1946)
However, Root, Stotz and Carpenter (1946) and Amatuzio et al (1952)
found that patients with mild disease responded to glucose administration
with an elevation of blood pyruvate, whilst those with severe disease
showed no response. These findings are compatible with the existence
of two types of diabetics: those requiring insulin, with no insulin¬
like activity in the plasma, and those not requiring insulin, with
demonstrable plasma insulin-like activity. (Lawrence, 1951; Bornstein,
1950; Vallance-Owen et al, 1955).
This problem was further explored by Smith and Taylor (1956) using
paper chromatography of the nitroquinoxaline derivative of the keto-acids.
These authors found no rise in the pyruvate level in insulin requiring
diabetics (after discontinuing insulin therapy for 12 hours), though
those not requiring insulin showed a response after administering glucose.
<X-Ketoglutarate was not significantly altered during the test, and fasting
levels of«(.ketoglutarate and pyruvate were found to be within normal
limits. This group have confirmed and extended these observations.
(Anderson, Marks and Smith, 1961; Anderson and Marks, 1962). Their
results confirmed the observations of Smith and Taylor, and in addition
they found that fasting, insulin requiring diabetics given 5 units of
crystalline insulin intravenously at the same time as they were given
100 g. of glucose orally showed a much greater rise in the blood
pyruvate concentration than did either normal subjects or obese, non-
insulin requiring diabetics treated similarly.
The authors explain the last observations by writing "When glycolysis
proceeds normally in insulin requiring diabetics, some of the cells
apparently have an altered permeability to pyruvate, which therefore
diffuse rapidly into the blood.1"
Moorehouse (1959) has shown that insulin requiring diabetics are
unable to deal with an intravenous load as rapidly as healthy subjects;
insulin therapy, achieving excellent clinical control of diabetics
did not abolish the abnormality, although it was sometimes reduced in
degree.
Anderson and Marks (1962) and Takanami et al (i960) found that
insulin requiring diabetics deprived of the hormone bad an abnormally
high urinary pyruvate excretion , both in the fasting state and after
ingesting glucose. The pyruvate concentration in blood was normal, and
the authors suggest that the kidneys of these patients cannot reabsorb
pyruvate as efficiently as healthy subjects or obese diabetics, both of
which groups showing very low rates of pyruvate excretion.
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In the insulin requiring diabetics, urinary pyruvate was not
significantly diminished when insulin was given with oral glucose, but
since the pyruvate load delivered to the kidney was more than doubled,
they reasoned that renal pyruvate conservation improved somewhat. The
rates of urine flow and urinary pH were similar in all three groups of
patients, so that the authors excluded a non specific osmotic diuresis
or pH effect as an explanation of the excessive pyruvate excretion.
10.1 3. The Adrenal Glands and Keto-acids.
Evidence that blood pyruvate concentration was raised in
pulmonary oedema, myocardial infarction, peripheral embolism, hypertensive
encephalppathy, cerebral haemorrhage, pneumonia, biliary colic and
haematemesis (Kleeberg and Gitelson, 1952; 1953; Gitelson and Tiberin,
1952) led GitelsonN^o conclude that the rise might be due to increased
adenocortical activity in the stress reaction. He studied the blood
pyruvate levels in patients given A.C.T.H. or cortisone:
a) Acute experiment (1 dose of drug)








25 i.u. A.C.T.H. 21 21 —
I.M.
100 mg. cortisone, 8 5 3
I.M.
B) Chronic experiment. Twenty patients given the same dosage of
drugs as above daily for 2-3 weeks, all showed significant rises in
pyruvate.
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Kerppola (1953) was fortunate enough to follow the development of
Cushing's Syndrome in three patients and presented his results for blood
pyruvate:
0.87 mg/100 ml. - 5 months later - 1.20 mg/100 ml.
0.53 rng/lOO ml. - 2 months later - 0.78 rng/lOO ml.
1.25 mg/100 ml. - 3 months later - 1.58 mg/100 ml.
He found a normal range of 0.35 - 0.67 mg/100 ml.
It is interesting that he found two cases of Addison's Disease
to have levels of 0.35 and 0. 63 mg/lOO ml. respectively. He found a
rise of blood pyruvate of from 10 to 100$ in 17 of 23 patients given
hydrocortisone over a prolonged period.
Hennemann and Blinker (1957) reported very high pyruvate levels in
13 patients with Cushing's Syndrome or who had been given long-term
cortisone therapy; in two of three Gushing patients submitted to
adrenalectomy, the postoperative level pf pyruvate was lower than the
preoperative. (One patient died at operation). These workers noted
a-ketoglutarate levels no different from normal.
Bennes, Wajchenberg, Fajans and Conn (1957) found that 10 patients
given prednisolone all had abnormally high pyruvate levels.
Whilst it would appear that enhanced adrenocortical activity may
cause a rise in blood pyruvate, it is important to recognise that not
all patients in this state have high blood pyruvate concentrations.
Thus Segal, iffy&ga^dMi (1956) reported two patients with
Cushing's Syndrome who had normal levels.
There seems to be no consistent relationship between high blood
levels of pyruvate and a diabetic type of glucose tolerance curve.
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This is illustrated by the results of Hills, Power and Wilder (1952) on
11 patients with Cushing's Syndrome.
No. of patients Diabetic glucose Raised fasting




Hennemann and Bunker (1957),however, claim that a raised fasting pyruvate
level precedes the appearance of an abnormal glucose tolerance curve,
as the severity of Gushing's Syndrome increases.
10.2 Liver Disease
Many workers have reported raised blood levels of keto-acids in
various liver diseases, though they have not been consistently raised in
all patients, and a few results have been in conflict.
Bianchess i( 1958) has reported that blooc^yruvate, measured by the
Friedemann and Haugen and chromatographic methods, was raised in hepatic
coma, but not in "compensated" liver disease, whilst Amatuzio and Nesbitt
(1950) reported normal levels in viral hepatitis, but "mild" elevation
in compensated cirrhosis; in hepatic coma the level was high and
fluctuated with the clinical state. Unfortunately the last two authors
did not quote actual values.
Seligson (1952), using his own chromatographic method, reported
elevated fasting levels in some patients:
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18 normal controls yielded: K-ketoglutarate level 13.0 + 1.5p M/litre
pyruvate level 73.0 1 16 p M/litre
Diseased patients revealed the results below:
Disease No. of
patients
Number of patients in











Cirrhosis 19 16 11
This work was followed by a well controlled investigation of blood
keto-acids in 27 patients with hepatic cirrhosis by Summerskill, Wolfe






Impending coma 32.3 154
Coma 39.7 225
They found, however, that the level ofofketoglutarate in £ of patients
in impending coma or coma and £ of the pyruvate levels in both these
states lay within the upper limits for the values in "compensated"
cirrhosis. These authors found that a-ketoglutarate, and usually the
pyruvate, rose and fell with a worsening or improvement of the patients
mental state; although the latter level occasionally continued to rise,
even when the patient improved.
49.
The authors suggest that there is some block in the utilisation
of pyruvate in cirrhosis and in coma, supporting the suggestion of Amatuzio,
and Nesbitt,S.,
Shrifter and Stutzman/(1952) who noted a prolonged rise in pyruvate after
administration of intravenous glucose to patients in coma, though normal
subjects or those with compensated cirrhosis did not show this phenomenon.
The significance of raised blood ammonia in hepatic coma is obscure,
and the level seems to have little prognostic value. Nevertheless, the •
observations of Recknagel and Potter (1951) that when ammonia is added
to rat liver breis or homogenates, the citric acid cycle is blocked and
acetoacetate is formed, led them t6 postulate that the ammonia combined
with«(ketoglutarate to form glutamic acid, thus reducing the concentration















Fig. 10. Effect of NHo on Krebs Cycle.
Heavily printed arrows represent effect of NH^.
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This effect of ammonia has been postulated as the mechanism responsible
for the cerebral symptoms in hepatic coma, amination of the a-ketoglutarate
rapidly reducing the small quantity of the substance present in brain.
Replacement of the a-ketoglutarate from the blood would be very slow
because of the considerable blood-brain barrier for this compound which
exists (Bessman, 1959} Eiseman, 1957} McArdle, 1957).
Some doubt is thrown upon this theory by the fact that the
severity of the neuropsychiatric symptoms cannot be correlated with
the blood ammonia concentration (Fisher and Faloon, 1956).
10. 3 Genetics and Keto-acids.
"Inborn errors of metabolism" and the principles of congenital
enzyme deficiencies were first enunciated by Garrod in his Groonian
Lectures (1909), but for many years the disorders he described were
regarded as medical curios? and it was not until 1959 that the theory
that "one gene controls the production, function and specificity of a
particular enzyme" was formally enunciated (Tatura, 1958} Beadle, 1958}
Lederberg, 1959). One of the first clues to an inborn error of
metabolism came with the description of a syndrome occurring in
infancy, of failure to thrive and mental defect, while the urine, some
6 to 8 weeks after birth, contained a substance which &ave a greenish-
blue colour with ferric chloride solution. This substance was later
found to be phenylpyruvic acid, a ketoacid absent from normal urine.
(Foiling, 1934).
Later work showed that the livers of these children lacked
phenylalanine hydroxylase (Jarvis, 1947} Udenfriend and Bessman, 1953)
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and phenylalanine was found to accumulate in the blood (Armstrong and
Bentley, 1956).
Meister, Udenfriend and Bessman (1956) 1956) demonstrated an
increase in phenylalanine transaminase activity, and suggested that the
increase was induced by a high level of phenylalanine] the delay in the
appearance of phenylpyruvic acid in the urine was ascribed by Knox and
Hsia (1957) to the time required to induce the increased enzyme activity.
Phenylpyruvic acid is also decarboxylated to form phenylacetic acid
which is conjugated and excreted as phenylacetyl glutamine (Meister,






















Fig. 11. Schematic representation of the
biochemical lesion in phenyl ketonuria.
(After Hsia, i960).
52.
Early recognition of this condition is of great importance, since
feeding the child on a diet free of phenylalanine results in an
apparently normal development (Hsia, i960).
A further syndrome of severe mental retardation, failure to thrive
and a rapid downhill course to a fatal termination some IS days to
20 months after birth has recently been described, and is associated with
a urine smelling of maple syrup.
Some 13 cases have now been reported (Menkes, Hurst and Craig, 1954;
Westall, Dancis and Miller, 1957; Smith and Strang, 195S; MacKenzie
and Woolf, 19595 Menkes, 1959; Dancis, Levitz,Miller and Westall, 1959).
Westall et al (1958) found a raised level of the "branch chain"
amino acids leucine, isoleucine and valine in both blood and urine, and
MacKenzie and Woolf (1959) found high concentrations of the ketoacids
corresponding to these amino acids in the urine.
The precise nature of the biochemical lesion in this disease has
not been defined. Transaminase activity for the branch-chain amino
acids was found in the tissues of a child with the disease (Westall,
Dancis, Miller and Levitz, 19§'8; Westall, Dancis and Miller, 1957;
Menkes, 1959; Dancis et al, 1959).
Menkes (1959) proposed a block at some point on the catabolic
pathway of the branch-chain ketoacids, and it was suggested that its
site was at the stage of oxidative decarboxylation of the keto-acids
(MacKenzie and Woolf, 1959; Menkes, 1959).
Unfortunately attempts by Dancis et al (1959) failed to pinpoint























































































































Pig. 12 The ca-taholism of "branch chain amino acids(Pruton & Simmonds,I958)
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to metabolise added leucine -1- ^C.
Figure 12 presents the normal catabolic pathway of leucine, iso-
leucine and valine, and it is evident that the absence of an enzyme
catalysing anybne step common to the degradative pathway of all three,
would cause an accumulation of the amino acids, and also of the
corresponding a-ketoacid.
Unfortunately none of the enzymes catalysing these steps has been
isolated. Until this is done, and their specificity defined, the
precise biochemical lesion in this syndrome must remain in doubt.
11. In Summary.
From the short survey presented above, it is apparent that the keto
acids are intimately involved in many metabolic processes, and that the
potential field of study, both in health and disease, is extensive.
From the beginning, it was obvious that it would be necessary to
limit the field of study, in order to obtain any useful results.
Part II, below, describes a study of methods, with a detailed
description of the method eventually chosen, and Part III describes the






As has already been noted, there is no ideal method for estimating
all the known ketoacids present in blood at the same time. The method of
De Schepper et al (1958) is the most comprehensive to date, the hydrazones
of five ketoacids being present in one chromatogram, although the "branch
chain" compounds all travel in one composite spot. It was decided to
investigate methods further, in the hope of separating and estimating all
the individual ketoacids present in blood:
1. Free ketoacids.
Magasanik and Dmbarger (1950) had successfully separated a-ketoisoval-
erate and a-keto-p-methylvalerate when the two compounds were chromato-
graphed as their free acids. Unfortunately these authors had not studied
the chromatographic behaviour of all the ketoacids which are of interest
here. Accordingly it was decided to attempt the separation of various
ketoacids using essentially their method. Complete experimental details
may be found by referring to the relevant papers (Magasanik and Umbarger,
1950; Umbarger and Magasanik, 1952) and only the outline is described
below:
After deproteinisation of the tissue of origin with the tungstic
acid precipitant of Folin and Wu, suitable aliipiots of some 10-50 pi
were spotted onto Eaton and Dikeman 613 chromatography paper, and
ascending chromatography, using one of two solvent systems, was carried
out:
Solvent system 1 = n-Butanol: formic acid = 95*5
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Solvent system 2 = S-Butanol: propionic acid = 95:5
saturate both mixtures with distilled water.
After drying the developed chromatograms, the paper was heavily
sprayed with an aqueous solution containing 0.1# of semicarbazide
hydrochloride and 0.15# of sodium acetate. After drying, the paper was
viewed by transmitted U.V. light when the opaque spot of ketoacid semi¬
carbazide could be identified against a fluorescent background. The spot
was outlined with pencil, cut from the paper and mixed with a dilute
solution of 2,4.-dinitrophenylhydrazine. Eventually the characteristic
pink colour of the ketoacid hydrazone was developed with KOH and the
compound determined colorimetrically.
The following minor modifications of this procedure were adopted.
1. Although the original workers found that only E. and D. 613 paper
was sufficiently inert to semicarbazide,the present author found that no
false U.V. opaque spots were produced on Whatman No. 1 or No. A paper.
Because E. & D. 613 was not readily available, the Whatman papers were
used, particularly No. 1, since it had the speed characteristics of the
paper used by Magaaanik and Umbarger.
2. Three solvent systems were used:
1. n-Butanol: formic acid = 95*5
2. sec-Butanol: propionic acid = 95*5
3. n-Butanol: propionic acid =95*5
(All three were saturated with distilled H^O).
Aqueous solutions of free ketoacids whose preparation is described
below, were made up in 0.1# (w/v) solution so that 20 mg. could be spotted
onto the paper in a convenient volume.
Initial experiments were undertaken using free pyruvate and
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a- ketoglutarate, and it was found that the two compounds travelled with
slightly differing speeds, but streaking was marked so that it proved
impossible to resolve a mixture of the two during a reasonable length of
solvent run.
The above observation, combined with the disadvantages listed below
led the author to believe that the method was unsuitable for the project
in hand:
1. In order to put a sufficiently large load of ketoacid onto the paper,
particularly in the case of a-ketoglutarate, it was necessary to spot the
paper with large volumes of deproteinised blood extract (Magasanik and
Umbarger found a limit of sensitivity of 5 pg) and 6 ml. of the extract
woild be required to achieve a 5 pg load for pyruvate.
2. The relative complexity of the method, with two separate drying
operations and with spraying, added further to its tedious nature,
rendering the process ill suited for application to clinical application.
3. The solvent systems were extremely sensitive to temperature change,
and, despite stringently carrying out the detailed instructions of
Magasanik and Umbarger in their preparations,(a fall of only a few °)C in
the atmospheric temperature resulted in separation of the phases.
4* Streaking. Before finally abandoning the method, attempts were made
to eliminate streaking:
a) small variations in the acid content of the systems had no
beneficial effect.
b) Careful equilibration for 24- hours with damp paper lining the tank
wall had no effect.
c) Substituting the slower No. 1 for No. 4 paper had little effect.
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5. Oxalacetate. An interesting finding was that large amounts (50 pg)
of oxalacetate spotted onto the paper produced a U.V. opaque spot when
sprayed with semicarbazide immediately, but subjecting the substance to
chromatography first made it impossible to locate the spot on subsequent
spraying.
The instability of oxalacetate has been mentioned in part I, but
decarboxylation with formation of pyruvate during development would
leave behind a residue still capable of reacting with semicarbazide;
presumably decomposition during this chromatographic procedure produces
some substance other than pyruvate.
Despite the excellent recoveries and reproducibility reported by
the authors, it was felt that the above preliminary findings were
sufficient to make the method unsatisfactory for the present study; it
must be pointed out that they found it of great value for the study of
relatively simple mixtures' in the culture media of micro-organisms.
2. Ketoacid hydrazones.
After the Experience described above, it was decided to return to the
old established method of studying the hydrazone derivatives, and to
attempt to evolve a method which would separate the derivatives of all
the ketoacids known to be present in blood.
2.1. Separation of Synthetic hydrazones by Chromatography.
2.1. 1. Material and Methods.
fa.) r^ruvate Hydrazone. Commercially available pyruvic acid
is said to contain up to 30$ of If-valerolactone (Clift,and Cook, 1932) and
it is necessary to use freshly distilled pyruvic acid to obtain its pure
hydrazone.
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Commercial grade pyruvic acid (British Drug Houses, Ltd) was twice
redistilled at 35 mm. Hg. pressure, the yield being approximately 50% of
the original yellow liquid} the distillate was colourless, leaving a dark
brown viscous residue, presumably mainly Y-valerolactone.
The distillate was dissolved in water to make a 20% (w/v) solution
and neutralised by the addition of 90% of its equivalent weight of solid,
"Analar" sodium bicarbonate. Six volumes of acetone were added to
precipitate sodium pyruvate, and the whole was kept in the refrigerator
overnight. The pyruvate was filtered off, dissolved in a minimum of water,
and treated with acetone until strong turbidity occurred. The mixture
was then warmed until the pyruvate dissolved, and cooled in ice and salt
mixture. The sodium salt was filtered off and dried over calcium
chloride at 50°C until its weight was constant.
(b) Purity of Pyruvate. The method of Clift and Cook (1932)
was used for estimating the purity of the pyruvate. This is dependent
upon the bisulphite reaction.
CH„.CO. C00H + NaHS0o = CH..COH.(0S0oNa) C00H
3 j i
The excess sodium bisulphite is titrated against iodine:
HS0~ + H20 + I2 = SO* + 21 ~ + 3H+
The bisulphiteT pyruvate complex is split by the addition of saturated
NaH.CO^ solution and the bisulphite equivalent to pyruvate thus estimated.
After preliminary standardisation of N/lO iodine solution against
thiosulphate, and of bisulphite solution against iodine, the purity of
the sodium pyruvate was found to be 93%.
(c) Preparation of Pyruvic Hydrazone. 0.2 g. of sodium
pyruvate was dissolved in 20 ml. water and a slight excess of 0.1% 2
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dinitrophenylhydrazine in 2N.HC1 added. A crop of crystals was thrown
down immediately and was filtered off.
The supernatant was left overnight in the refrigerator and a further
crop of crystals removed the next morning.
The two crops were combined, dried overnight over CaCl^ and re-
crystalised from glacial acetic acid.
( d) Ketoglutarate Hydrazone. Fresh a-ketoglutaric acid (M.P. 110°C.,
uncorrected; from L. Light and Co., Colnbrook) was used, the details
being as for pyruvate.
The dry hydrazone was recrystallised from cold ethyl acetate
using petroleum ether (60-80°B.P.)
( e ) Acetoacetate Hydrazone. Acetoacetic acid was prepared as its
sodium salt by the method of Shaffer (1921):
Ethyl acetoacetate was saponified with 2N.NaOH overnight at 37°C.
The solution was cooled and acidified to Congo red paper with HoS0 .«£ 4
The solution was extracted 4 times with g- volume of ether in a
separating funnel, and the ether layer then shaken with water made slightly
alkaline with NaOH. This alkaline solution contains the sodium aceto¬
acetate and was used in any experiment in which acetoacetate was required,
after passing N2 through the solution to remove acetone formed by
spontaneous decomposition of the p-ketoacid.
The filtered solution was kept in the refrigerator.
( f ) Ketoisovaferate Hydrazone: KIV was obtained from the Sigma Chemical
Corporation, St. Louis, Mo, and the hydrazone prepared as for pyruvate,
recrystallisation being undertaken from ethyl acetate, as in the case of
oxalacetate.
60.
( g ) Ketoisocaproate. The free acid was obtained as a liquid from
the Californian Corporation for Biochemical Research.
The hydrazone was prepared in the usual way and the resulting
compound recrystallised from hot water.
( h ) q-keto-3-methylvaleric hydrazone. Only a small quantity of KMV
was available, generously donated by Professor Alton Meister of Tufts
University School of Medicine, Boston, Mass.
5 mg. of the sodium salt was dissolved in 10 ml. H^O and the
exact equivalent of the D.N.P.H. solution added.
The precipitate was filtered off and dried, but it was not
recrystallised.
( i ) Acetone Hydrazone. This was prepared in the usual way from
"Analar" acetone in a 5% (v/v) aqueous solution and was recrystallised
from glacial acetic acid.
Purity of the Hydrazonea.
For the purpose of this work, M.P. determinations were regarded as
satisfactory criteria of purity, since the elemental composition of some
of the hydrazones resemble each other closely; indeed, those of KMV and
KIC are merely isomers of each other.
Keto-acid Found M.P.. Comments M.P. quoted Reference
"G." (Uncorr- °C
ected)
Pyruvate 216 Sharp M.P. 218 1
a-ketoglutp 219 " 219 1
a.rsL"fcG
Oxalacetate 211 * 211 1
a-ketoiso- ^ _ X96 2
valerate
a-keto-p- j_66 Sharp M.P. 168 2
methylvalarate
a-ketosiocap- - 160 2
roate
Acetone 126 Sharp M.P. 126 1
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Reference 1 = El Hawary + Thompson, 1953.
Reference 2 = Meister + Abendshein, 1956.
It will also be noted that the standard of purity of only pyruvic
acid was determined (see above). This was necessary because of the high
instability of the compound; the other a-ketoacids are more stable, and
the M.P. of the hydrazone was regarded as adequate proof of purity.
2.1» 2. Chromatographic Separation of the synthetic hydrazones.
Reference to the published methods for chromatography of ketoacid
hydrazones revealed that a-ketoglutarate, with a very low Rf value, is
well separated from the pyruvic acid, and both are separated from the
"branch chain" ketoacids which travel together in a composite spot (De
Schepper et al, 1958).
The first studies undertaken, therefore, were on the chromatographic
behaviour of the branchchain ketoacids, with a view to possible separation,
a) Conventional solvent systems. Saturated solutions of the hydrazones
prepared above were made in distilled water and were renewed at frequent
intervals.
Usually 20 pE of each solution were spotted onto the chromatography
paper using a micro-pipette and dried by a stream of compressed air, at ram
temperature*to dry tho
Whatman 3 MM paper was used in this study. Altmann et al (1951) and
De Schepper, Parmentmer&Van da?Hsaghe (1958) found that the spots were
more compact on buffered paper; accordingly the strips were dipped in
0.1 M Na barbitone - HC1 buffer of pH values, 6,7,8,9 and 10, and then
blotted dry; they were allowed to dry at room temperature. Unbuffered
paperswere used,also.
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The hydrazone solutions were spotted at the origin(which was 10 cm.
from the narrow end of a 10 x 40 cm. strip of paper) and each was 2 mm.
diameter and 2.5 cm. from its neighbour.
After overnight equilibration with the vapour of the aqueous phase
of the solvent in a sealed glass tank the organic phase was introduced,
and descending development carried out for 12 hours.
Three solvent systems were used:
1. n-Butanol: ethanol:water = 5 J 1: 4 (Meister, 1956).
2. n-Butanol: ethanol: 0.5N. NH.OH =7: 1: 2 (El Hawary, 1953).
4
3. Isoamylalcohol: ethanol: H^O = 5: 1: 4 (Altmann et al, 1951).
In the case of all three, although a-ketoglutarate and the isomers
of pyruvate hydrazones were well separated from each other and from the
"branch chain" derivatives, these last three were not resolved.
This experience was, apparently, shared by De Schepper et al (1958)
and by Meister and Abendschein (1956) who studied 14 solvent systems,
eight of which were found unsatisfactory for some technical reason, and
the remaining six failed to separate the branch chain derivatives.
It was therefore decided to investigate some less conventional
systems.
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t>) Acidic Solvent Systems.
(i) Theoretical Considerations.
In a theoretical treatment of partition chromatography,Martin(1959)
showed that:
a = A1* -]IRf I-------- Equation I.
where a is the partition coefficient of solute "between water and
solvent phases.
A1 is the cross sectional area of the solvent phase
As is the " " " " " water "
and Rf - Movement of "band of solute
Movement of solvent front
From equation I,
In a - In A1
^ In
As (If - *] Equation 2
But for a given solvent system,paper and temperature A1 is constant,and
As
therefore
In a = K +lc [i - Equation 3
Bate-Smith and ¥estall(l950) called the variable quantity on the right
hand side of equation 3 the"Rm value",i.e.
Rm *= Infl _j
|_Rf I — - — - - - Equation 4
Further thermodynamic considerations led Martin(l959) conclude that
the "Rm value is actuallyi^be sumoof similar values for the individual
component groups of the whole molecule,e. g.
Rm glycine " ARm RH2 + A Rm CH2 + ARm COOH -Equation 5
These theoretical considerations have received experimental
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verification from Bremner(l95l) and Serchi(l953) for amines,from Bate-Smith
and ¥estall(l950) for plant pigments and from Bush(l960) for steroids.
Consideration of equation 4 shows that Rm and Rf are closely
related and that knowledge of Rm values of certain molecules in specific
solvents should allow a prediction of Rf values to he made,where ideal
solutions are dealt with.
The solvent systems used in the chromatography of keto-acid
hydrazones have "been universally neutral or alkaline,with the exception
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¥allgren an&¥Nordlund found that their acidic solvent system
was unstable,and others have had similar experience with this system.
Thus Bate-Smith and Westall(l950) found that the slow esterification of
butanol caused changes in Rf values of plant pigments,when all other
conditions remained constant.
Magasanik and Umbarger (1950) tried to avoid these changes
by allowing their solvent systems containingbbutanbl and formic or propionic
acid to "age" for a month before use.nevertheless,these workers found their
solvents to be unstable,as did the present author.
In studies of the effect of solvent composition on hydrazone
separation,Bush and Hockaday(l960) compared ifchree acidic: solvent systems
with eacl/other and with the butanol:3% aqueous system used by
Cavallini and Prontali(l949) •
The three systems contained hydrocarbons: J■
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The three hydrocarbon systems of Bush(l960 )
Code lame Composition(by volume)
T/A75 Toluene/acetic acid/water 4:3:1
LTI1/A85 Light petroleum*/toluene/acetic acid/water 10:10:17:3
D/A 90 Decahydronaphthalene/acetic acid/water 10:9:1
*- fraction hoiling at 100-120°^.
In their rather brief report,Bush and Hockaday(l960)
pointed out that;
1. Rm values decreased with increasing chain length of the chain
length of the hydrazone,but
2. The ARm value is greater in the acid systems than in the alkaline
system they studied.
Thus there seemed to he a reasonable prospect of separating all the
major hydrazones completely,using thes solvent systems,although Bush
and Hockaday merely reported the chromatographic behaviour of the
a-ketoglutarate and pyruvate derivatives;they claimed that the latter
did not form two separate isomeric spots,but that it merely formed one
slightly elongated spot.
Hockaday(I96l) reported that the hydrazones decomposed
in the acidic conditions,but that the percentage lossrwas directly
proportional to the load on the paper.
(2) Experimental.
Materials
1. Ligroin(light petroleum,fraction boiling I00-I20°C,M.andB. Chemicals)
2. Decahydronaphthalene ('!Decalih',B. D.H)
3. Toluene(sulphur free,B.B.H.)
4. Acetic acid(Reagent grade,M,andB.)
Chromatography paper
10 cm. by 40cm, strips of Whatman paper,nos,1,4 and 3M.M. were prepared.
Solvent systems.
The three solvent mixtures of Bush were prepared,and allowed to stand
at room temperature for I week before use.
Standard hydrazone solutions
Aqueous solutions containing 0.5g/litre were prepared so
that 20pL contained 10 pg.
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Method.
10 mg. of each hydrazone were applied 11.5 cm. from the end of the paper,
so that spots 1—2 mm. in diameter were obtained.
The papers were hung in a well sealed glass chromatography tank with
some of the aqueous phase of the relevant solvent system in the bottom.
It was found necessary to seal the tank well because of the volatility
of the solventsj this was achieved by putting a small layer of silicone
stopcock grease (Edwards High Vacuum, Ltd.) between the lid and the rim of
the glass tank. It was further important to line the tank walls with
chromatography paper in order to achieve saturation of the strip with
aqueous phase before development; failure to do so caused severe streaking
of the spots. The details of the solvent run will be seen below.
(iii) Results. The addition of the large, polar dinitrophenyl-
an
hydrazine molecule to/a-ketoacid would, presumably, increase both its
polarity and also the degree of ionisation of the acidlic carboxyl group.
As a consequence, one might expect the hydrazones to have low
solubilities in the hydrocarbons which possess a low polarity. Thus,
for example, n-hexane, a major constituent of ligroin has a dielectric
constant (E) of 1.89 at 20°C and E for toluene is 2.438, whilst
E for amyl alcohol =16.0
E for n butanol = 17.8
E for ethanol =25.7
(Figures from Handbook of Chemistry and Physics, 43rd edition. Chemical
Rubber Co., Cleveland, Ohio, 1961).
In view of the above facts, it was not surprising to find that the
hydrazones travelled very slowly during development of the chromatograms,
whilst the solvents possessing low viscosity, ran very rapidly.
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To move the hydrazones sufficiently to resolve a mixture, it was necessary
to allow the solvent to overrun the paper and to drip off its end, which
had been serrated, to promote even flow. Because of this overrunning, no
Rf values are quoted here.
The three solvent systems successfully separated a-ketoglutarate
and pyruvate from each other and from the branch chain ketoacids. Pyruvate
was found to produce two spots, and not one, contrary to the reports of
Bush and Hockaday.
Irrespective of the solvent used, development was continued until
the fastest moving hydrazones, those of the branch chain ketoacids,
reached the lower end of the paper. The time required for full
development varied with the solvent systems, presumably due to differences
in viscosity.
Thus system LT11/A85 required a run of approximately U hours, whilst
that for system D/A90 was 12 hours.
Considerable inconvenience was occasioned by the finding that the
speed of running was extremely sensitive to temperature change, and a rise
in the atmospheric temperature of 2°C caused the speed to double in some
experiments. Consequently^ close attention during development was
necessary, in order to avoid loss of the fastest spots.
Whilst no difficulty was experienced in separating a-ketoglutarate
and pyruvate hydKBones, results with the branch chain ketoacids varied
somewhat.
1) Irrespective of solvent system or paper used, a-ketoisocaproate
and a-keto-jJ-methylvalerate ran with the same velocity.
68.
2) In system T/A75 all three branch chain compounds ran with the same
velocity.
3) In systems D/A90 and LT11/A85, however, the ketoisovalerate travelled
slightly more slowly than the other two compounds; experiments with systems
of varying composition showed that one composed of ligroin: acetic acid:
water = 20:17:3 (by volume) produce slightly better separation of keto¬
isovalerate. Nevertheless, this could only be achieved when small
loadings of the branch chain ketoacids had been applied to the paper.
Thus when 10 pg of KIV and of KMV hydrazones were applied in a mixture at
the origin (equivalent to approximately 5 pg of the free acid), true
separation could not be obtained, a composite streak with a waist between
the two components being formed.
Since analysis of blood extracts would normally contain much greater
quantities of these compounds than those alone, it is evident that
separation could not be obtained.
In addition to the above observations, other objections were found
to the use of this method.
1) Ligroin is of variable composition,and it might be expected that
chromatographic behaviour would vary from batch to batch; the experiments
described above were all carried out with one batch.
2) These solvent mixtures, especially D/A90, are particularly unpleasant .
3) These acid solvent systems decompose the hydrazones, leaving a dense
yellow deposit of unknown composition, at the origin.
Bush and Hockaday (I960) noted this phenomenon, and claimed that the
amount lost was proportional to the load of each hydrazone, although they
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appear to have studied merely o-ketoglutarate and pyruvate.
They claim (l96l)>, to reduce this loss by keeping the paper loading
to a minimum; to do so with the ketoacids studied in this work would be
impossible, because of the widely differing concentrations of the compounds
in blood and to put a suitable quantity of branch chain ketoacid hydrazones
from blood on the paper would result in the amount of ketoglutarate
derivative being immeasurably small.
The slightly differing Rf values of KIV and KMV + KIG could be
exploited to achieve separation of the KIV by using longer runs at the
same time incurring the serious disadvantages of increasing hydrazone
decomposition and of causing the spots to diffuse greatly.
Because of the objections outlined above, it was decided to abandon
this method.
c) The use of Ion exchange Papers.
The phendl-formaldehyde and polystyrene based ion exchange resins
have been in use for many years (Adams and Holmes, 1935; D'Alelio, 1945)
but they were not used for paper chromatography except in a few relatively
unsuccessful experiments when paper had been dipped in a suspension of the
resin particles and allowed to dry (Lederer, 1955; Lederer and Kertes,
1956).
However, cellulose is itself a cation exchanger of very low capacity
since it contains a few free carboxyl groups. Thus Harrison (1912) found
that HG1 appeared in the eluate after passing NaCl through purified cotton.
Successful attempts have been made to use cellulose as a matrix to
carry ion exchange active groups.
The cellulose molecule consists of D-gluco-pyranose units joined by
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1)4- glycosidic bonds, ana. it is to the five —OH groups of carbon atoms,
1*2,3 and 6 of the glucopyranose residue that the substituents have been
attached, although substitution is thought not to have occurred homogeneously
either throughout the cellulose molecule or within the glucopyranose
residues (Balston and Balston, 1961).
(i) Ion exchange papers available. Both cation and anion exchangers
are now available, and the cation exchangers have been successful in the
separation of proteins (Sober and Petersen, 1954). However, the
present problem is that of separating large complex anions, and it is the
anion exchangers which are of primary interest.
Anion Exchangers.
1) Amlnoethyl-cellulose ("AH") This compound may be represented as
cell.-O-CH^.CH^.NH^ and as a primary amine it possesses very weakly basic
properties. At pH values higher than 9.0 it does not exhibit any anion
exchange properties.
The stability of the material to alkalis or acids which may cause
scission is very high.
2) Diethyl-aminoethyl-gellulose ("DEAE") This substance is a substit-
uent of AE cellulose:
Cell. - 0 - GH2-CH2.N (C2-H5)2
Being a tertiary amine it is more strongly basic than AE, but its other
properties resemble those of AE.
3) "Ecteola" cellulose. This is a complex exchanger prepared by the
reaction between cellulose, epichlorhydrin and triethanolamine. It
contains tertiary amino groups, but is more weakly basic than DEAE.
(ii) Choice of Exchanger and of its form. Although both carboxy-
methyl cellulose (a cation exchanger) and DEAE cellulose had been available
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for several years in the form of powder and floe, and had been used
successfully in the separation of proteins by column chromatography, it
was not until 1959 that the material made into sheet form was used to
separate aminoacids by Knight (1959a, 1959b) and this form became
commercially available in the latter part of that year.
At this stage of the present work only AE and DEAE were commercially
available, EGTEOLA cellulose being scheduled to be marketed later. The use
of these papers for the separatior/of the hydrazones was explored. Unfortun¬
ately little information was available at this time about the properties
of the material, the valuable review of Jakubovic and Knight only becoming
available in late I960.
On general principals, however, it was assumed that the maximum
capacity of the exchangers would be in the acidic range of pH, a fact
subsequently confirmed by Jakubovic and Knight (I960).
In addition, these papers have low exchange capacities, and the
recommendation of Knight (i960) was followed, buffers of low molarity being
used.
(ii) Experimental Details.
Choice and state of papers. Whatman AE "30" of nominal exchange
capacity 0.6 meq/g. and DEAE "20", nominal capacity 0.4- meq/g. were used.
The papers were used in 2 states:
1) Paper received from the manufacturers, without modification, was
spotted with the synthetic hydrazones and the chromatogram developed as
described below.
2) Cycled paper; Three inch wide strips of paper were washed with
0.1 N.NaOH for 24. hours, after which it was washed with distilled water
until the effluent was neutral to B.D.H. narrow range indicator paper.
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This usually took 12 hours. Cycling was conveniently carried out by
treating the strips as descending chromatograras, the NaOH being added to
the trough of the chromatographic tank. Washing was undertaken by sucking
off the NaOH and adding water to the trough, after rinsing four times.
The strips were dried at room temperature for 4.8 hours, after which
they were used in the same way as the untreated strips.
Buffers: These were all 0.1 M., except where otherwise stated.
KHg.PO^/Na^H.P0^ buffer was used for pH values above 6, Na acetate/acetic
acid at lower values.
Knight (personal communication) recommended that both the AE and
DEAE papers be used at pH values less than 8. Accordingly,two phosphate
buffers (pH 7.12 and 6.0) and two acetate buffers (pH 4-7 and 3.7) were
prepared; the pH values were measured using the conventional type of glass
electrode pH meter.
Development of the Chromatogram.
10 fig of the hydrazones in fresh aqueous solution were applied to a
line 10 cm. from the end of a 7.5 cm. wide strip of ion exchange paper
using conventional methods (described above).
The paper was then hung in a sealed glass chromatography tank in
the usual arrangement for descending chromatography. It was left over¬
night to saturate with water and the following morning one of the buffers
described was introduced into the trough.
First series.
The papers as they were received from the manufacturer were spotted
with the hydrazones and chromatograms on DEAE and AE paper developed in
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parallel by the addition of buffer to the trough. In both cases the
solvent was allowed to overrun the paper, since it ran very rapidly, whilst
the solute spots ran slowly . In all, L, experiments were performed using
the buffers described above.
In order to distribute the various spots down the length of the paper,
it was found necessary to allow the solvent to run for 18-24 hours, by which
time the ijiost rapid spots had travelled some 30 cm.
The speed of travel resembled, in most respects, those in
conventional systems i.e.
increasing i a-ketoglutarate hydrazone
speed I Pyruvate hydrazone.
y Branch chain ketoacid hydrazones.
However, several observations are of considerable importance.
1) Pyruvic hydrazone, well separated from that of a-ketoglutarate,
showed marked separation into two spots, the faster of which travelled
close to the branch chain ketoacid hydrazones.
2) The KIV spot travelled slightly faster than KIC and KMV, both of
which possessed the same velocity.
3) A disappointing finding was the severity of streaking which occurred
in all spots. The length:breadth ratio of the spots of the developed
chromatogram was approximately 3:1 and was such that KIV hydrazone
remained unseparated from the other two branch chain ketoacid hydrazones
when the chromatogram was fully developed, and the faster pyruvate spot
became incorporated in the spot of the branch chain ketoacids.
The above observations applied to all four buffers, and differences
in pH appeared to have no effect on chromatographic behaviour of untreated




The same experiment as in series 1, but using paper in its OH form,
was carried out.
The results were similar to those of the first series except that
streaking was much more severe, with a length:breadth ratio of approximately
7si, so that it was not possible to achieve separation.
Before abandoning the use of ion exchange paper for this project, a
few additional experiments were undertaken:
1) The molarity of the buffers was increased, first to 0.1, and then to
1.0, with no effect on resolution.
2) Although practical difficulties made it impossible to attain true
gradient elution, a chromatogram was allowed to run for 10-12 hours, after
which the trough was emptied and either
a) a more molar buffer solution of the same pH was introduced or
b) a buffer of the same molarity but lower pH was introduced, or
c) 1.0 M. NaCl solution was introduced.
Steps (a) and (b) had no effect on resolution, and (c) merely
resulted in very wide diffusion of the spots.
Clearly the full potential of this new material had not been
explored, but it was not felt justifiable to continue work on this aspect
of the problem. Accordingly this type of chromatography was abandoned,
but because of its probable future importance, some aspects are discussed
here.
It would appear that the most likely explanation for the streaking
noted on the chromatogram is that adsorptional fbr.oes have a very great
effect on the chromatographic behaviour of the compounds, in aodition to
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any possible ion exchange effect.
Thus Davies (1949) and Davies and Thomas (1951) found that molecular
adsorption effects were great in the case of the chromatography of amino
acids, organic acids or bases on ion exchange columns, and that the effect
increased with rising molecular weight.
This observed cause may explain the higher speed of travel of the
KI7 hydrazone, which has a smaller M.W. than KMV and KIC.
Moore and Stein (1952) have noted that the rate of movement on a
column of polystyrene exchanger is dependent upon affinity of the resin
for both the ionic and non-ionic portions of a molecule, the latter force
being determined by adsorptional forces and by the degree of hydration
of both solute and column.
Jakubovic and Knight (I960) have found that incorporating water
miscible organic solvents into the aqueous buffer solutions used for
development has produced more compact and definite spots of amino acids.
These authors think that the introduction of the solvent adds
partitional and other effects to the ion exchange effects, and they have
suggested that the factors affecting separation on polystyrene found by
Moore and Stein (1952) also affect ion exchange celluloses.
Jakubovic and Knight (I960) report having explored the use of buffers
with organic solvents only tentatively, and, perhaps, a re-examination of
the problem might yet produce a method for the separation of one, at least,
of the branch chain ketoacids.
The reason for increased streaking after cycling the paper is obscure.
Perhaps the most likely explanation is that adsorptional forces are
increased, and that converting to the-OH form changes the degree of
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hydration of the exchanger, which is an important factor controlling
affinity of solute for exchanger.
The method finally chosen is described "below.
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d) The method chosen.
Considerable time was expended in the unsuccessful
exploration of the methods described above,and it was decided that it was
necessary to use an already established method,despite its inadequacy; the
most comprehensive was that of de Schepper,Parmentier and Van der Haeghe(l958)
and this method was explored with a view to its use.The wedge shaped strips
used by these authors were found to be inconvenient to use,and since the
method offered no better separation than conventionally shaped strips,it
was decided to use parallel sided strips 10cm. wide and 40cm. long,downward
development being undertaken. In all other respects,the method used here
is exactly as described by the original authors.
The various steps of the method as it was finally used,and the
details of each step,with particular attention to those precautions
necessary for the achievement of reproducibility,are described below.
I. Collection of samples,
a) Blood
Blood was drawn from a vein into a sterile,dry syringe at room
temperature,and with no fist clenching. On occasions when a tourniquet had
to be used,sufficient blood was withdrawn within 90sec. of application.
After withdrawal,the blood was immediately ejected into
precipitant as a thin stream ,and shaken briskly.
Tungstic acid was chosen as precipitate for several reasons:-
1. Trichloracetic acid filtrates from deproteinised blood,if kept overnight
in a refrigerator,give a falsely high level of keto-compounds,apparently
derived from the T.C.A. itself(Friedemann and Haugen,1943;Goodwin and
Williams,1952)
Further,the precipitant destroys pyruvic acid if left overnight
in mixtures.(leish,1957)
2. ffietaphosphoric acid causes emulsion formation,when extracts are shaken
with organic solvents(®l Hawary&Thompson,I953)
3. Tungstic acid has been widely described as a satisfactory precipitant
(Seligson&Shapiro,1952;Klein,I9415d-e Schepper,Parmentier and Van der Haeghe,
I958;Taylor & Smith,19555 Cavallini & Frontali,1954)5although the last
authors noted occasionally that emulsion formation when the "protein free"
supernatant was shaken with ether for extraction purposes. They thought
that"it was probably due to incomplete deproteinisation", an impression
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confirmed, by the present author,for emulsion formation only occurred
when the amount of blood was greater than that which the tungstate could
deproteinise; under these conditions,a white,filmy deposit (?protein)
formed at the ether/water interface. This problem was easily overcome by
ensuring that a slight excess of precipitant was always present in the tubes
into which the blood was ejected.
Preparation of the Precipant,
1. 2/3N. sulphuric aoid was prepared and stored separately.
2. 10# (w/v) sodium tungstate (Analar) was prepared and stored separately.
3. Distilled water.
De Schepper,et al recommended a composition of:
blood; tungstate: sulphuric acid: water 1:1:1:3 ( by volume ),
but it was necessary to compensate for an unduly alkaline batch of sodium
tungstate by using more acid,and the optimum composition was found to be:
blood: tungstate: sulphuric acid: water 1:1:1.2:3 ( by volume ).
The volume of blood usually deproteinised was 5ml.,but
sufficient precipitant was put into the tubes to deproteinise 6ml. of
blood,thus ensuring completion of this proceedure.
Initially the blood was lysed by the correct quantity of water
and sulphuric acid, after which the sodium tungstate solution was added,but
this method caused inaccuracy in the estimation of the quantity og blood
used. At this stage of the study, 6" by, I" glass stoppered test tubes were
weighed,and l8ml. of distilled water with 7.2ml. Of the sulphuric acid
were added to the tubes,after which they were weighed again.After the
addition and lysis of the blood,6.0ml. of tungstate were added,the whole
shaken,and reweighed. Thus any error in the measurement of the tungstate
was immediately reflected in the weight of blood taken,since the latter
was obtained by difference.Errors were found to be frequent in the early
phases,and the method was therefore slightly modified. In order to avoid
the labour of multiple pipetting when preparing the tubes, 0.2 N.
sulphuric auid was prepared,and 25ml. of this solution added to the tubes ,
instead of (7.2ml. of the 2/3N. sulphuric plus 18ml. distilled water).
The weighed tubes were filled with both the ready-diluted
sulphuric acid and the sodium tungstate solution,after which the tube was
weighed again.
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Thusjin summary,preparation of "the tubes entailed four steps:
1. Weigh tube.
2.Add 25ml. of the 0.2F.sulphuric acid.
3.Add 6.0ml. of 10$ sodium tungstate.
4.Weigh again.
The tjibes prepared in this way were then taken to the bed side,where the
blood was added in a thin stream,and the whole shaken vigorously.Provided
that the investigator did not omit these last two precautions,this proceedure
did not appear to prevent successful precipitation of the blood proteins,
and it avoided the necessity of trying to add exactly 6.0ml. of tungstate
under circumstances which made the possibility ofaan error in pipetting
great. The mixed precipitant remained stable for 3-4 hours,after which a
white precipitate of tungstio oxide started to form.
After collection in the above manner,the precipitated protein
mixture was allowed to stand for IOmin, at room temperature.
b) Urine
Urine was collected into a clean bottle containing 0.5ml.of
2011. sulphuric acid for each 100ml. of urine.
The whole sample was kept at 4°C. in the refrigerator,until
used for analysis,the usual time interval being 4-5 hours.
The urine was deproteinised according to the instructions of
McArdle(l957). Where the S.G. was 1.02 or more,6ml.of urine were added to
26ml.of 5$ metaphosphoric acid,but where the S.G. was belbw I.02,increasing
quantities of urine were added to decreasing quantities of more concentrated
metaphosphoric acid,the amount of urine depending upon its S.G.,in such a
way that the final concentration of MPA was not less than 4$.
In practice,this precautions was unnecessary,since the samples
studied were morning collections,in which the S.Q. was never less than
1.020.
2.Formation of the Hydrazones.
The deproteinised blood or urine samples were centrifuged at
1,000 G for IOmin.,and the supernatant filtered to remove particles of
precipitated protein which had been held up by surface tension.
A known aliquot of the filtrate,usually 20ml.,was pipetted into
6" byll"glass stoppered pyrex tubes,and 2.0ml. of 0.1$ dinitrophenylhydrazine
in 2W. HC1 added.
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The mixture was allowed to stand for 30 minutes or]longer,at room temperature,
after which extraction was commenced.
(A dilute solution of DNPH in HG1 was chosen because it was
possible to make it up into solution at room temperature,avoiding the production
of the benzotriazole artefact caused by heating. The quantity of concentrated
HCl(Analar) required to give a final concentration of 2W. was taken,and
2,4 dinitrophenylhydrazine added,ground with the HCl and left overnight.
Water was added to the required concentration the next day. The solution
was stored in a polythene bottle.)
3. Extraction of Hydrazones.
The superiority of diethyl ether over other solvents has
already been mentioned in Part I,and"Peroxide Free"ether (May & Baker)
was used. Unlike ethyl acetate,ether causes no emulsion formation with
blood extracts,but it does so with those of urine,when it was easily
broken with centrifugation.
Unfortunately,ether is so volatile that it proved impossible
to achieve quantitative transfer of the supernatant ether to the flask
in which it was to be evaporated, by the use of an ordinary Pasteur
Pipette. It was also difficult to avoid carrying over water with the
ether supernatant. These problems were solved by the construction of
a small scale suction transfer device (suggested by Dr.S.C.Frazer ).
Yellow polythene stoppers (B 19 size,from W.J.Elliot & Co.,
Pontypridd ) fitted the 100ml. flasks used for evaporating the etherial
solution.:,and the red disc in the top was easily removed to reveal the
hollow structure common to the larger sizes of these stoppers. The
metal components were conveniently obtained from clean hypodermic
and lumbar puncture needles:
I. A fine hypodermic needle was introduced through the flat lower
surface of the stopper and thereafter the sharp bevel was filed so that its
point and sharp edge were removed,thus avoiding the splitting of the Wo. I
or Wo.2 bore "Sterivac" polythene intravenous cannula ( Allen & Hanbury,Ltd.)
which was pushed over the bevel until a tight fit was achieved. After
attaching the cannula,the final position of the inlet needle was adjusted ,
<?nd the butt end of the needle carefully removed in such a way as to avoid
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distorting the lumen; this precaution, combined with the careful filing of
the end left,resulted in an even,smooth flow of ether into the flask,
avoiding turbulance and splashingg,
2. A wide "bore needle was inserted through the flat stopper end
from above,so that its point was 3—4mm. below the lower surface.
3. The length of the polythene cannula was adjusted to an acceptable
value,and a lumbar puncture needle,treated in exactly the same way as the
fine inlet needle,was inserted into its end.
This relatively simple piece of apparatus allowed accurate,
quantitative transfer of supernatant ether with no losses andaa
minimum of unwanted water. The total capacity of lumbar puncture needle,
cannula and inlet needle was not greater than 0.2ml.,and it was rinsed
after each extractions,by sucking 2.0ml. of ether into the flask.
Figure 13 shows a sketch of the stopper,and it may be seen in use in
figure 14.
SUCTION
Fig. 13. The Suction Transfer Stopper.
Fig. 14. The Suction transfer Apparatus in use.
Repeated extraction of the 22ml. of reaction mixture was undertaken by
shaking with ether in the glass stoppered tubes. The tubes were left for
3-4 minutes,to allow the layers to separate,and by extracting four tubes
serially,a "flow" system was established,and no time wasted between each
extraction. Five 10ml. aliquots of ether were found to be most satisfactory,
the final aliquot being colourless after shaking with the aqueous layer.
After the final extraction, the polythene cannula was rinsed
with 5.0ml. ether, and the walls of the flask were washed with a further 5ml.
in order to wash any solute deposited high on the flask wall (due to splashing)
was washed to the bottom.
Using this method of transfer,losses appeared to be constant
and small.
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4. Evaporation of the Etherial Solution.
A .ground glass connector piece was inserted into the flask
and the whole was transferred to the suction apparatus shown in Fig 15.
Here the flask contents were evaporated under reduced pressure in an
atmosphere of nitrogen,at 25°G.
By adjusting the nitrogen "leak" and the suction,rapid
evaporation without hoiling and splashing could "be obtained,and the ether
was removed in 20 minutes,the residual water requiring a further 45min.
Since no other published method mentions the use of nitrogen
during evaporation,it is worth noting that it was impossible to achieve
reproducibility of results when the ether solution was evaporated with
an air leak,but the introduction of a nitrogen atmosphere resulted in an
immediate and dramatic improvement,to give the degree of precision noted
below.
Presumably the hydrazones are decomposed by oxidation,under
the circumstances described above,although the nature of the process
has not been studied further. Smith(l960) notes that "prolonged
evaporation, even in nitrogen, has been reported to decompose certain
hydrazones, particularly of pyruvic acid",although he gives no reference
to the relevant literature.
Fig. 15 The Evaporation Apparatus.
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5. Preparation of the residue for Chromatography.
I.Oml. of I.0U. ammonium hydroxide was added to the flask
containing the dry residue,and the walls wetted in order to take up the
acidic hydrazones. It is of great importance that all areas he wetted,the
latter "being achieved "by swirling the flask. Unless the flask walls are
grease free,it is not possible to achieve the efficiency of wetting required,
and it was found necessary to "boil the flasks in concentrated "Diversey
Pyroneg" (Deosan,Ltd.) for 20 minutes after each use. Swirling must he
continued for AT LEAST five minutes,after which small particles,prohahly
of neutral hydrazones or of free DFPfi, remain undissolved.
I.Oml. of Analar chloroform was added to the flask,and the whole
carefully swirled until the remaining particles dissolve.The mixture of
phases was theii poured into a I5ml, conical tube,and centrifuged for 5-I0min.
at full speed in a small M.S.E. centrifuge.
6, Preparation of Chromatography Paper.
50cm. by 10cm. paralleleddged strips of chromatography paper
were used,and the characteristics of Whatman Bos. 1,4 and3MM papers were
studied,in addition to the effect of buffering the papers at different pH
values.
The strips were buffered by dipping them in a trough containing
O.IM sodium barbitone/HCl buffer at pH 7.0,8.0,8.6 or 9.0,drying at room
temperature for 24 hours before use.
Although buffered paper produced more compact spots than the
parent papers,they had little effect on separation of the individual
keto-acid hydrazones. Since pH 8.6 appeared to produce the most compact
spots,it was decided to use this buffer.
Of the papers, No.I proved to be most satisfactory; the fast
ITo. 4 paper produced rather more diffuse spots than did 3MM and Bo. I, and a
study of- the recovery of known quantities of hydrazones after chromatography
showed the recovery from Bo.I to be 3$ higher than that from 3MM.
To obtain reproducible results, it is particularly important
that the area of corresponding hydrazone spots in different developed
chromatograms b© equal. Thus in one of the early experiments,equal quantities
op pyruvic hydrazone were applied to separate papers,but after development
one area was some 40$ larger than theoother,and produced a 15$ lower recovery.
It was not difficult to achieve equal areas in practice,by
maintaining the conditions under which the ammoniacal supernatant was
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applied, to the paper constant,and "by applying it to a line at the origin
of constant length (3.7cm.)
The relatively large volumes of supernatant were applied to
the origin "bymmeans of a chromatography pipette made by drawing out the
tip of a graduated I.Oml. pipette to a fine point,in such a way that the
proximal bore was undistorted ,and it could still be used to measure the
volume of supernatant applied.The tip was bent,and a fine polythene tube
aPplie(ljitself being drawn out to a fine point which was lightly smeared
with silicone stopcock grease to prevent solution running along it in
a retrograde direction. A sketch diagram of the pipette tip is seen in
Figure 16,
Figure I6, The chromatography pipette.
Using this pipette,the desired volume of ammoniacal supernatant
was applied to the paper,using a stream of compressed,filtered air at
room temperature. 0.35-0.50ml of blood extract,or 0.1-0.2ml of urine
extract were the usual volumes,and 0.35ml. could be applied in 30 minutes.
The strip was suspended in an all glass chromatography tank
and left overnight for it to equilibrate with the vapour of the aqueous
phase,after which the organic phase was introduced,and descending
development carried out for 12 hours. The tanks,and later the strips ,when
drying,were kept in the dark,since pyruvic hydrazone is reported to be
sensitive to light(Markees,I955)•
7. The solvent system used.
None of the convential systems has advantages over any other,
so that the one of de Schepper,Parmentier and Van der Haeghe(l958) was
used;
n-butanol: ethanol:water 4 J15 5 (^7 volume).
The mixture was kept in a separating funnel for 3-4 days






















Figure 17. Diagram of the chromatograms of keto-aoid. hycLrazones.
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"bottom of the chromatography tank,the remainder being kept in contact
with the butanol phase; failure to take this precaution resulted in
streaking of the spots during development.
The Rf values observed in many experiments are presented
below,
Parent Keto- acid. Rf value of hydrazone
From blood extract 1 From pure keto-acid solution
a-ketoglutaric O.I4-O.I9 0.15-0.20
slow pyruvic O.46-O.56 0.44-0.54
fast pyruvic 0.59-°-69 0.57-0.67
KIV 0.86-0.91
KIC 0.84-0.94 (elongated spot)
KMV O.84-O.9I
Branch chain spot 0.78-0.89
Aceto-acetate O.84
Free DNPH,slow 0.45-0.55
" " ,fast 0.59-0.68
It will be seen that considerable variations occur in the
Rf value of any one keto-acid,attributed by many t<5 slight variations
in solvent composition,temperature,etc.(Smith,i960). Nevertheless,
in any one chromatogram,the a-ketoglutarate, the two pyruvate,and the
"branch chain"spots are well separated,and a diagram of the chromatograms
may be seen in Figure 17.
Confirmation of the identity of each spot was made by carrying
out chromatography on the ammoniacal extract of two aliquots of the same
serum,to one of which was added a pure sample of the keto-acid in question;
on eluting the spots,those corresponding to the keto-acid in question were
shown to have a higher concentration on the"test"chromatogram.
It will be seen that free 2,4-dinitrophenylhydrazine travels
with speech equal to those of the pyruvic hydrazones,so that it is always
necessary to include a "hydrazine blank" when studying the keto-acids
with this method.
Additional confirmatory evidence for the site,in the developed
chromatovram,of the various hydrazones may be obtained by the use of:
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The alkali dip reagent (Stewart,1953)
After dipping the developed chromatogram in^2$(w/v) solution
of sodium hydroxide in 90f° ethanol,the individual keto-acid hydrazones
develop a colour characteristic of some of them.
Chromatograms were prepared from the pure keto-acid;;
hydrazones which had "been prepared above,and after development the
alkali dip reagent was applied.
Synthetic hydrazone
spot



















The dip reagent was afterwards applied to a chromatogram
prepared from "blood extract; the 3a-ketoglutarate spot gave the
expected colour,hut the spot corresponding to the slower pyruvate
isomer produced a spot which was entirely "brown except for a narrow
upper border which was yellow,presumably due to the free DNPH
travelling with the pyruvic hydrazone. The faster pyruvate spot was
entirely yellow,but the "branch chain spot" presented an interesting
appearance; the spot was very diffuse,spreading a considerable
distance beyond the margin of ultraviolet opacity,in the direction
of solvent flow,and itd colour was brown,except for a narrow band
running across its centre,which was yellow. Since KIC hydrazone
produces an elongated spot whose extemities are different colours
(and due to the formation of isomers,as discussed in Part I of this
thesis) ,the most likely explanation of the appearance of the branch
chain spot would seem to be that the slowest,brown band and the yellow
band are due to the isomers of KIC hydrazone,whilst the fast brown
band is due to both KMVand KIV hydrazone together. This suggestion
is in keeping with the experience that the long streak of KIC
88.
hydrazone "travelled slightly more slowly than those of KMV and KIV
in experiments in which the chromatographic behaviour of the
individual compounds was examined.
8. Elution of the spots.
After development,the papers were dried overnight at
room temperature in a darkened room,and the outline of the hydrazone
spots marked with a pencil,using transmitted ultraviolet light
("Chromatolite",Hanovia,Ltd.).
The spots were cut from the paper in such a way that there
is a border of uncoloured paper around the pencilled margin,particularly
in the case of the "branch chain spot", where diffusion beyond the
pencilled margin was found to be marked (see above).
Elution was carried out by rolling the strips carrying
the hydrazones into loose coils,placing them in the bottom of test
tubes and adding the required volume of I.ON. NaOH. By using this
technique,both surfaces of the paperwetted by the sodium hydroxide,
and elution was most efficient; quantitative studies of elution of
known quantities of hydrazones from chromatograms showed that a higher
recovery was obtained by using this technique,than by using the usual,
conventional method of cutting the spots into strips,which appeared
to prevent efficient wetting of the paper,because the strips lay against
each other,even when the tube was shaken. The coil was allowed to stand
for 5 minutes,before it was pulped using a fine glass rod,after which
the pulp was mixed carefully. The pulp was allowed to stand for a further
5 minutes.
This elution process must be carried out with great care,
in order to obtain maximum recovery.During preliminary experiments,
it was found that the efficiency of elution was increased when the
NaOH:paper ratio was increased; however,addition of a large volume of
sodium hydroxide solution produced a very faint pink colour,and it
was necessary to strike a compromise;and the volumes of ITaOH chosen
to elute each spot are presented below:
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Hydrazone Volume of NaOH to elute (ml.
3a-KG (from blood ) 2.0
a-KG (from urine ) 5.0
Slow pyruvate 5.0
Fast pyruvate 5.0
Branch chain K-As 7.0
The pulp was centrifuged at I,200G for 5 minutes,after
which the tube was vigorously shaken,in order to dislodge particles
of paper which were held at the water surface.Centrifugation with
the same conditions as above was repeated. Without this "double
centrifugation" technique,paper particles were introduced into the
spectrophotometer cell and falsely high readings obtained.
9. Estimation of the Hydrazones.
After centrifugation, the supernatant solution was
removed with a Pasteur pipette,and introduced into the silica micro
cells (icm. light path ) of a Unicam SP 500 spectrophotometer.
The optical density of the pink colour was measured against
a blank prepared by eluting a corresponding area from a chromatogram
of an ammoniacal extract,in which the original test solution(blood or
urine) had been replaced by distilled water. The optical densities
were measured at 440mp,except for a-ketoglutarate hydrazone,whose
optical density was measured at 420m|i. The actual quantity of
keto-acid present in the original test solution was calculated from
formulae presented below.
The method has been presented step by step above,and particular
stress has been laid on those features which were found to be of great
importance in obtaining reproducability;it remains,however,to obtain
some estimate of the precision.of the method:
t. Quantitative evaluation of the method.
The first step was to establish the stability of the pink
colour of the hydrazones in sodium hydroxide solution; the pure hydrazones
were dissolved in I.ON. NaOH solution,and the optical density measured
at intervals up to 2 hours afterwards,and it will be seen from table 6 A
that,even at 120 minutes,the optical density is only slightly less
than that at the time of dissolving,in the case of all hydrazones examined.
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Ta"ble6A The stability of the colour in I.PIT, NaOH.
Time after Optical density of hydrazone
adding NaOH (min.) a-KG Pyruv. KIC KMV KIV
2.0 .381 .605 .405 .441 .814
2.5 .382 .605 .406 • 440 .817
3.0 .370 .605 • 405 .442 .814
3.5 .378 .603 .407 .438 . 816
4.0 .379 .604 . .442 .815
4.5 .381 .605 .400 .438 .815
5.0 .379 .605 .398 .438 .817
6.0 .383 .607 .395 .442 .814
7.0 .380 . 60 6 .402 .442 , .816
8.0 .380 .604 .405 .435 .816
9.0 .378 .602 .402 .442 .813
IIOvO .367 .599 .405 .439 .814
15.0 .370 .605 .406 .445 .820
20.0 .372 * o\o U-> .404 .442 .816
25.0 .374 .604 .402 .439 .817
30.0 .368 .595 .398 .428 .799 J
60.0 .362 .592 .394 .422 .792
120.0 .355 .583 .386 .415 .783 1
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2.The Absorption S-pectrum of the Hydrazones in I.ON. sodium hydroxide.
The pure hydrazones prepared above were dissolved in the
sodium hydroxide,and the optical-densities determined at wave-lengths
between 370m(j. and470 mp,using the Unicam SP500 spectrophotometer.
The results are recorded graphically in figures 18-22,
where the ordinate, represents the ratio:
^Amax
Optical density at ¥,L. X
Optical density at W.L. of maximum absorption.
It will be seen that the maximum absorption occurs,in all cases,
except a-ketoglutarate hydrazone, at or about 440mp,and the optical
densities of all unknown solutions were subsequently measured at this
wavelength;the exception,a-ketoglutarate hydrazone,showed a peak of
absorption at 420mp,and the optical densities of solutions of this
hydrazone in laOH were subsequently measured at that wave-length.
The absorption spectrum of free 2,4-dinitrophenylhydrazine
over the same range of wave-lengths was prepared,and is presented
graphically in figure 23. The absorption spectra of the different
hydrazones eluted from chromatograms resembles those of figures 18-22
so closely,when measured against the "hydrazine blank" that they are not
reproduced here. Similarly,the spectra of the two spots produced on the
chromatograms of free 2,4-DNPlI (i.e. the "hydrazine blanks", Kj. and ^ )
closely resembled the spectrum of the parent compound,and figure 23 is
representative of all three.
The quantity of barbitone buffer eluted from the chromatograms
along with the hydrazones is difficult to define,but it was thought wise
to see whether the presence of a relatively large quantity of barbitone
buffer had any effect on the pH of the eluate,and whether this change
had any appreciable effect on the absorption spectrum.Figure 18 shoes the
spectrum ff a-ketoglutaric hydrazone dissolved in a mixture of NaOH and
barbitone buffer;because the spectra were so very similar,it has been
necessary to draw the curves on separate scales to prevent them overlapping.
A similar lack of effect was found with KMV-hydrazone.
Fibres 18-23 The absorption s-pectra of the keto-acid
hydrazones and, free DEPH.



























x—x—x Solution in I-O N. NaOH.
pH= 13-25
x—x—x Solution in 1-25 N.NaOH:
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Figure 18. The absorption spectra of a-ketoglutarate hydrazone in
1.01. UaOH and in laOH/barbitone "buffer 4/l.ExI^x^a0H) °-525
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Figure 19. The absorption spectrum of pyruvic hydrazine In I.ON.NaOH.
EXmaj£= 0.606.
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Figures 24-28 The calibration graphs for the
keto-acid hydrazones.
g-ketoglutaric hydrazone.
0-25 0-50 0-75 IOO
CONCENTRATION OF HYDRAZONE (mq./IOO ml. NoOH)
Fig. 24. The calibration curve for f;a-ketoglutarate(optical densities at 420m|i)






















* corrected for difference between cells.
Pyruvic hydrazone.
CALIBRATION GRAPH FOR PYRUVIC HYDRAZONE
(at 440 mjj)
CONCENTRATION OF P-HYDRAZONE (mg. / lOOml. NaOH)
Figure25.
Weight of dry hydrazone 5.03mg, dissolved in 500ml. NaOH.
Sample "Stock"solution,ml. I.OH.NaOH,ml. Optical density* Concentration,mg/looml
I Undilut ed 0.770 1.01
2 4.0 1.0 0.624 0.81
3 2.0 2.0 0.385 o. 50
. 4 1.0 4.0 0.158 0.20
-* corrected for difference between cells.
Keto-isocaproic hydrazone.




CONCENTRATION HYDRAZONE (mg./IOO ml. NaOH)
Figure26.
Weight of dry hydrazone,4-68mg;dissolved in 50ml. I.ON. NaOH

























* corrected for difference between cells.
Keto-isovaleric hydrazone.
Ol 0-2 0-3 0-4 0-5









CALIBRATION GRAPH FOR KIV-
HYDRAZONE (at 440 mp)
400
Figure27
Weight dry hydrazone 4.22mg.,dissolved in 2,000ml. of sodium hydroxide
solution. This volume of sodium hydroxide was necessary because of the





















g-ke to-3-me thyl-n-valeric hydrazone.
CALIBRATION GRAPH FOR KMV
HYDRAZONE (of 440mjj)
CONCENTRATION HYDRAZONE (mg./IOO ml. NaOH)
Figure28.
Weight of dry hydrazone, 3.44mg.jdissolved in 50ml. sodium
hydroxide,to form the "stock"solution.
Sample Stock soln.
ml
I.0W.]\Fa0H,ml. Optical densf Goncentration,mg/l00ml.
I 0. 50 2.0 0.835 1.38
2 0.50 3.5 0.515 0. 86
3 o, 50 4.5 0.420 0.69
4 0.50 5.5 0.343 0.57
5 0.50 9.5 0.210 0.35
* corrected for differences between cells.
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3.Establishment of Calibration Curves.
Pure synthetic hydrazones,prepared in section 2.I.I.,and
dried to constant weight,were weighed out and dissolved in a known
volume of sodium hydroxide solution,to produce a "stock" solution,which
was then diluted with varying volumes of sodium hydroxide solution,to
produce a range of dilutions which might he expected in extracts from
biological fluids. It was necessary to take great care with the initial
weighing and dissolving of the hydrazone in sodium hydroxide, since an
error at this stage would he reflected in all the dilutions.After
comparing the optical density of two silica micro-cells containing
I.OH. HaOH,the optical densities of the varying dilutions of hydrazones
was measured against I.OH. HaOH as a blank. The light path was Icm. long,
and the machine an SP 500 spectrophotometer. The results for five
hydrazones are presented below,in graphical and tabular form.
Since it would be inconvenient to calculate the blood
concentrations on each case by tedious,prolonged computations,a formula
was derived to apply to each keto-acid,and the method of calculation is
presented in Appendix 2.Examination of the calibration curves (figures 24
shows that they obey Beer's Law over the ranges of concentration
studied,and therefore it is valid to apply the formulae to calculating
the concentrations in most samples of blood.
4. Reproducibility of the method.
In order that the experimental conditions should resemble
normal working conditions as closely as possible,serum was used as a
source of the keto-acids to be studied. Quadruplicate samples of fresh
serum were subjected to the extraction and chromatography proceedure
described above. Those sera in which it was thought that there may be
abnormal concentrations of keto-acids(e. g. hepatic disease) were
rejected. Several "lots" of 4 samples were processed for/lte^kefo-acids,
as isolated from blood;an estimate of the standard deviation(S.D.) for
each "lot" of 4 samples was obtained,after which it was necessary to
see if the concentration of keto-acid in the sample had any effect on
the magnitude of the S.D. This was undertaken by calculating the
coefficient of regression of the S.D. upon the mean concentrations for
each"lot". The results are presented here in a summarising table,but
the full details,and the method of computation are presented in detail
in Appendix I.
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The reproducibility of the method.
Keto- WO.of Range of Range of







a-KG 6 *181.2-577-7 t3.0*E4.5
Pyr. 6 771.0-1881.9+3.82=4674 0.88-7.60
P*<0.01
0.1 > p^o.05
0. 4 > P^>0.3
Br.Ch 4 1754-9-
2513.8 iI2. 9-17. 6 2.19-3.94
* Prohahility that b differs from 0 due to chance.
Unfortunately the range of keto-acid concentrations found
in the samples of serum studied was higher than that of normal "blood,
although this fact was not discovered until near the end of the study,
when sufficient data on the normal "blood concentrations had "been
accumulated,and no one appears to have reported this higher concentration
of keto-acids in serum;nevertheless,the ranges reported here,in the case
of a-ketoglutaric and pyruvic acid,are of the same order as the raised
concentrations observed by various authors,in some diseased states,when
blood concentrations were studied. (See Part i). Only the range of
"branch chain" keto-acids reported in this small study of serum
appears to be very much higher than the normal blood concentrations,
and whether this range of concentrations is very much different from
that which would be observed in disease is difficult to confirm,be cause
of the few reports of studies on the blood concentrations of these
compounds.
acceptable order,both in view of the dependence on chromatography,and
also because of the relatively small quantity of a-ketoglutaric acid
present in blood.It is interesting that only the regression coefficient
for a-ketoglutaric acid is significant,suggesting that the S.D. is
effected by the concentration in the serum.
5. The recovery of added keto—acids.
Known quantities of pure keto-acids were added to serum,
and the whole put through the extraction and chromatography process,
along with equal aliquots of the same serum to act as "serum blank1 ".
The author feels,however,that the reproducibility is of an
94.
Two samples each of the "serum blank",and serum with added keto-acid
were processed at the same time.The difference between the optical density
values of the final eluates from the chromatograms of these two groups
represented the added keto-acid.
q-ketoglutaric acid recovery.
From the formulae calculated in Appendix 2,the relevant formula
is:
concentration of free keto-acid( [ig/l00ml.) — 0. D.-x A xD *146
m XB XC XE/C326
Substituting: A^.Oml. ; B-0.5ml. 5 C-I5.0ml.
I) =3Iml, ( 5ml. serum+I5ml. water-»6ml. H^SO ^"5rol. tungstate )
E-=5ml. 5 m=0.520.
concentration of free keto-acid = O.B. x 3 x 31 x 146
0.520X0.5 VI5.0X 5.ox 326
From this expression,the estimate of the quantity of keto-acid
added may be made,and the difference between this estimate and the
quantity actually added represents the quantity lost during the proceedures
to which the serum was subjected:
qg. pure O.D. O.D. Diff.
A
Estimate of 'Jo recovery Mean recovery
acid "serum serum between a-KG added, |ig
of each group^






































































From Appendix 2,the relevant formula is:
concentration of pyruvate(as sodium salt)
— O-P.* 10 *31* IIP
0.770 ko.5 *15.Ox 5.0 x-326
where A =10.0ml. B =0. 50C-I5.0ml. D = 3Iml. E= 5.0ml.
and m — 0.770






































































Recovery of the branch, chain keto-aoids.
Only the recoveries of KIV and KIC were studied,"because
of the small quantities of KMV available.
a) KIV
Substituting in the relevant formula in Appendix 2,
I
concentration of free keto-acid == P.P.* 10x31x113
0.59X0.50 xl5.Ox 5.Ox 293
where m =.0.590,and the same volumes of serum,protein free supernatant,





































O.O67 18.1 58.1 59. 8
b) Keto-isocaproate recoveries.
In a similar way to the above,
Concentration of free keto-acid(as sodium, salt)
O.D.X 10 x 31x152
0.625*0. 50*15.0* 5.0*310



















































The figures presented, above for reproducibility and recovery are similar
to those published by other workers who used similar methods(e. g. Seligson
and Shapiro,1956; McArdle,1957).
Prom an inspection of the results for recoveries,the
corrections to be applied to the formulae to correct for losses
were estimated as being:





Branch chain 60 100
60
The branch chain keto-aoids.
Since these compounds were not resolved on the chromatogram,
it was necessary to decide which one of the three compounds the mixture
should be reported as. Some guidance to this problem was obtained by
calculating the molar extinction coefficient for the hydrazones of
the three individual keto-acids.
The molar extinction coefficient is defined by:
D=X.1.C. where I) =Optical Density
X-=-Molar coefficient
Is length of light path
C -molar concentration of solute.
Prom the calibration curves obtained from the pure
hydrazones,the value of X was calculated:
-I -I




It is apparent that there is little difference between the values
presented above; it was decided to use the KMV calibration graph
as the standard against which to measure the branch chain acids.
98.
After establishing the method to "be used,it was applied







Studies on the blood ketoacid. concentrations in several different
diseases were undertaken. The values obtained in each disease are
reported and discussed together below.
2. Normal sub.iests.
^•l. Single Samples. Blood was collected from 16 normal subjects,
observing the precautions mentioned on page 34> &nd was processed according
to the method described in Part II.
Except for M.S., A.S., J.G., P.B. and U.N., blood samples were
obtained at least 4 hours after the last ingestion of food and/or drink;
the five exceptions had undergone a 12 hour fast before sampling.
The individual results may be seen in Table 6, and are summarised
here:
Ketoacid Range Mean S.D. Coefficient of
(pg/100 ml.) (|xg/l00 ml). variations, %.
103 - 27 26
643 - 186 29
588 -152 26
A comparison of these results, with those of other authors reported
in table 5, shows that they are of the same order, but that the mean
concentration of a-ketoglutaric acid is lower than that obtained by most
authors studying the hydrazones by chromatography, although it is in

































5.70 36.21 0.50 0.080 0.025 84 0.348 0.124 701 0.196 0.037 853
G.W.
(M)
5.02 36.43 0.50 0.057 0.007 116 0.320 0.053 820 0.100 0.029 500




5.15 36.55 0.50 0.073 0.023 87 0.483 0.123 812 0.186 0.056 778
;
B.C. 5.40 36.73 0.50 0.147 0.044 168 ■ 0.630 ,163 1018 0.167 0.048 683
(M)
H.H. 6.24 40.57 0.50 0.093 0.032 96 0.419 0.128 454 0,113 0.037 41.7
(M)
K.K. 5.77 36.79 0.50 0,096 0.032 98 0.441 0.128 635 0.152 0.037 618
(F) ill
G.C. 5.57 35.94 0.50 0.107 0.040 99 0.509 0.107 823 0.125 0.037 474
(M)
J.C. 5.44 36.76 0.50 0.101 0.043 93 0.442 0.107 718 0.110 0.037 416
(M)
D.B. 5.35 36.70 0.50 0.093 0.024 122 0.299 0.161 300 0.111 0.037 428
(F)
R.L. 5.47 36..SO 0.50 0.070 0.030 64 . 0.437 0.125 667 0.158 0.041 665
(M)
S.F. 5.70 37.09 0.50 0.072 0.030 65 0.399 0.125 566 0.127 0.040 478
(M)
D.F. 5.36 37.04 0.50 0.098 0.032 125 0.311 0.092 519 0.114 0.034 533
(F)
J.F. 5.55 35.86 0.50 0.133 0.032 126 0.424 0.147 568 0.187 0.054 731
(F)
F.R. 5.60 36.88 0.50 0.078 0.032 71 | 0.316 0.147 352 0.123 0...54 383
(M)
U.N. 5.56 36.92 0.50 0.098 0.030 108 0.387 0.122 559 0.164 0.040 695
(F) — 1
Table 6. The blood concentration of keto-acids in normal subjects.
There may be several explanations for this difference:
The quantity of a-ketoglutaric acid in blood is so small that accurate
measurement of its concentration is extremely difficult. Thus, an
inspection of the results in table 6 reveals that the optical density
of the a-ketoglutarate blank is relatively high by comparison with that
of the actual a-ketoglutarate spot. The difference between the two is
very small, and a small reduction in the optical density of the blank
would cause a relatively large increase in the measured blood
concentration.
The primary standard in "D.N.P.H. methods" is the parent keto-acids,
whose purity it is often difficult to define. This criticism is made
by the advocates of enzymatic methods using lactic dehydrogenase or
glutamic dehydrogenase (Hess, 1955; Seitz et al, 1955; Segal,Blair and-..
Wyngaiarden, 1956; Marks, 1961), and Segal,B3jB%s.:-armbn¥yngaaMem.,(1956)
claim that D.P.N.H. and D.P.N., the primary standards of these methods,
can be obtained in high purity, although they appear to discount the
possibility that their enzyme preparation may contain small quantities
of other enzymes using D.P.N.H. and D.P.N, as coenzymes.
As judged by the M.P. of its hydrazone, the a-ketoglutaric acid used
as a primary standard in the present work was very pure, and vigorous
methods of drying the hydrazone standard to constant weight were adopted.
Thus the solutions of this hydrazone dissolved in NaOH to prepare the
calibration graph would have a minimum unit weight:optical density ratio;
in methods where less stringent drying was adopted, this ratio would be
higher, and, since small quantities of the substance were being measured,
this variation would cause a significant difference to the concentrations




smaller influence on the final results obtained for pyruvate and branch
chain ketoacids, since these are present in higher concentrations.
The method used in this study was that of de Schepper, Parmentier and
Van der Haeghe (1958) with minor modifications, and inspection of their
results suggests that the ranges of blood concentrations of the different
ketoacids are essentially the same as those reported here. These authors
did not quote mean values, but inspection of a "scatter diagram" of normal
blood concentrations suggests that the mean values are very similar to
those obtained in the present study.
In addition to the above observations, it will be seen that there is
a wide scatter of the normal values found, the magnitude of the coefficient
of variation being of the same order as those reported by Seligson and
Shapiro (1952), El Hawary and Thompson (1953) and McArdle (1957). As
was noted on page 36, differences between means of small samples may be
due purely to sampling error.
2.2. Spontaneous Variations in blood concentration and urinary
excretion.
Many papers have been published describing the blood ketoacid
concentrations in fasting subjects based upon an analysis of a single
blood sample, but very little has been published about possible spontaneous
variations in these values over different periods of time. For this
reason, it seemed advisable to obtain some indication of any possible
spontaneous variation and of its magnitude.
2.2. 1. Day to day variation. In order to make the conditions
at sampling both as basal and reproducible as possible, samples of blood
and urine were collected from subject M.S. (a 26 year old healthy male)
immediately on awakening in the morning. In this way, the effect of
103.
exercise,-which increases the "blood concentration of ketoacids(see Part l),
and also has an effect on urinary production of the ketoacids(McArdle, 1957)
was minimised.
In the same way,since sampling took place some 12 hours after
the last ingestion of food or drink,any possible dietary factors were
minimised. "BBlood samples were obtained on eight successive mornings,
and the overnight urine on seven of these mornings.
The results are reported in tables 7 and 8. The values for the
blood concentrations were calculated in the normal way,bu$ it is necessary
to make some observations about the mode of presentation of the results
for urinary ketoacids.
Urine was voided on retiring to bed at 11.30 p m. and the overnight
urine collected at 8,00 a m the following morning, so that the time of
collection (in all 7 samples) was 8.5 hours. The volume varied considerably,
as did the concentration of the ketoacids. The effect of varying volume
was avoided by estimating the quantity of ketoacid produced per hour,and
the method of calculation is described in appendix 2.
Prom the results obtained,it is apparent that there is a considerabl
day to day variation,both in blood concentrations and urinary production
rates.
Prom the values,it does not appear that blood concentration
or overnight volume influences the ketoacid production rate,and the
regression coefficient calculated for production rate upon blood
concentration and upon overnight volume (using the method described in
Appendix l) was itotTsignif icant ,for both a-KG and P.
* +kul it** nx




























































































































































Day to Day Variations of urinary g-ketoacids.
Time of collection = 8.5 hours.
Day Vol.urine Vol.NHOH on O.D. of O.D. of Production rate,
ml. paper,ml. if K.G. x P mg/hr.
KG. P
1 245 0.20 0.468 0.450 ' 1.04 0.53
2 247 0.20 0.411 0.452 0.92 o *44
3 450 0.20 0.288 0.374 1.22 0.76
4 265 0.20 0.480 0.706 1.19 0.90
5 280 0.10 0.232 0.295 1.20 0.79
6 215 0.20 0.492 0.483 0.97 0.50
7 425 0.10 0.132 0.137 1.02 0.61
Means 0.93-9.60 0.65-0.17
x Optical densities connected for O.D. of corresponding blank.
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2.2.2. Variations in "blood concentrations over a short period.
The concentrations were studied over the period of 4 hours in
two subjects.
The subjects were two patients in hospital for the
investigation of diseases not known to have an effect on intermediary
metabolism,the first for idiopathic epilepsy and the second for
essential hypertension (although the first patient was eventually
found to be neurotic,with a hysterical epilepsy.)
The subjects were fasted overnight (12 hours) and blood
collected over the next 4 hours,whilst they rested in bed.Table 9
shows the results obtained.
The most striking overall feature is the cosiderable
fall in pyruvate concentration over the 4 hour period,the concentration
of the other compounds showing no consistent trend. A similar
change in pyruvate was noted by Segal,Slaj'i;^.rand &pAg§.&3rriLia'i(l956).




Subject 1 Subject 2.
1 0.0 KG 196 147
P 721 600
B.C. 6l6 826
2 0.5 KG 185 150
P 716 459
B.C. 577 990
3 1.0 KG 175 153
P 592 510
B.C. 493 959
4 2.0 KG 153 149
P 520 421
B.C. 499 773
5 3.0 KG 160 144
P 649 382
B.C. 490 968




Table 9. The levels of g-ketoacids in 2 fasting sub.jects over 4 hours.
All concentrations |ig/l00ml. blood.
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3.The keto-acids in Disease.
3.1. The Adrenals.
The rather conflicting results obtained, for the blood
concentration of keto-acids in patients with abnormal adrenals has
been noted on page 46.
Values obtained in three cases of Cushing's Syndrome
and one of Addison's Disease are presented in table II.
The urinary I7-ketosteroids and I7-ketogenic steroid
production rate were estimated in the routine laboratory of the
Department of Clinical Chemistry of The Royal Infirmary of Edinburgh,
and hydrocortisone production rate was estimated by Mr.(now Dr.)
G.F.de Witt in the same department.
By measuring the rapidly falling specific activity of plasma
hydrocortisone (cortisol) after administering 4-C1^ labelled Cortisol
intravenously,it was possible to estimate the turnover rate of
endogenous Cortisol.(De Witt,I96l)
The production rate was also estimated by studying the
urine of these patients.The principal metabolite of Cortisol in
urine,tetrahydrocortisone, was isolated by chromatography,and
from a consideration of its specific activity and the total
radioactivity of the 24-hour specimen of urine,the 24 hour production
rate was estimated. Only a very brief description of the method has
been given here,and full details may be obtained from the Ph.D.thesis
of Dr.de Witt(l96l).
Normal values found were,
from urine:8. 8-18. 9 nig/24 hour,
from blood:l6.I-30.2 mg./24 hour.
The value from blood is,in fact,the turnover rate during
2jg" hours on the morning of study,extrapolated to represefat a 24 hour
value,whilst the value from urine estimates the total 24 hour
production,and since Cortisol production varies diurnally,with a
maximum in "he morning,the former value is higher Vhib normal
diurnal variation is absent in Cushing's Syndrome(Forsham,I9< 1)
Cope and Black(l998) and De Witt(I96I?) regard the Cortisol
production rate as the most sensitive measure of the hyper-adrenocorticism
of Cushing's Syndrome.
ioq.
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On the hasis of these measurements,the Cortisol production
rate deviates markedly from normal values in all four cases,"but yet
no abnormality is evident in the blood ke'to—acid concentrations,except for
that of the branch chain compounds in case 3,which is slightly above the upper
limit of the normal range.
Perhaps the most interesting observation is the finding of a
normal blood pyruvate concentration in all 4 cases,in keeping with the
observations of Segal,Blair & Wyngaarden, (1956) and Hills,Power & Wilder(l952)
who have found normal levels in patients with the same disease.
Hone of the cases of Cushing's Syndrome studied here showed an
abnormal glucose tolerance,even though ¥illiams(l960) quotes figures to show
that 81% of patients show the disturbance. It is probably unwise to assume
that the blood pyruvate and glucose concentrations are related.Thus Segal,
Blair & Wyngaarden( 1956) have reported two normal subjects in whom the blood
glucose concentration remained constant,whilst the blood pyruvate concentration
fell progressively throughout the period of the test.
The precise site of action of Cortisol is not clearly understood,
but Long,Katzin and Pry(l940) showed by balance studies that the liver of
mice contained increased quantities of glycogen after administering cortical
extract,and that glucose production from some nitrogen containing substance,
probably protein, was increased.The adrenal corticoids appear to inhibit
protein synthesis (Hoberman,1950),and to increase the rate of release of
amino acids from the tissues of eviscerated animals(Bondy,1949;Ingle,
Prestrud & Hezamis,1950;Bondy,Ingle &Meaks,1954).
C—11 oxygenated steroids appear to accelerate the degradation
of amino acids (Russel,1955) •
A striking increase in glutamic—pyruvic transaminase activity
has been demonstrated in the livers of rats given cortisone (Rosen,Roberts
& Hicholl,1958),although these authors regard the effect as being indirect
since an increase of similar magnitude may be induced by giving a high
protein diet to normal rats,and even adrenalectomised animals show a less
marked,but similar response.
III.
The observations hy others of a high fasting blood pyruvate
concentration in patients with Gushing's Syndrome,and of an abnormaly great
rise in blood pyruvate on the administration of glucose ( Frawley,I955 5
Henneman & Bunker, 1957; Hennes,Wajchenberg,Fajans & Conn, 1957; Fajans,I96l)has
been regarded as indicating a block in the utilisation of pyruvate.
In support of this theory,Frawley & Shelly, (1961) have demonstrated
a diminished rate of disappearance of injected pyruvate during corticosteroid
therapy. Glenn,Bowman, Bayer & Meyer(l£6l) observed a decreased rate of
oxidation of exogenous glucose after Cortisol administration in adrenale eternised
pyruvate
rats, andindicated that the inhibiting effect occured at thqlevel of
glucose metabolism.
Fajans(l96l) infused sodium pyruvate into normal subjects before
and after administering prednisone,and found that the normally ensuing
rise in blood citrate was inhibited by the steroid.
Thorn,Re'nold & Cahill (1959) observed increased hepatic
synthesis of glucose from pyruvate under influence of Cortisol.
Thus it would appear that Cortisol inhibits pyruvate utilisation,
and the latter is thus increasingly available for the synthesis of glycogen.
Perhaps the explanation lies in the observations that corticosteroids
inhibit the oxidation of D.P.N.H.'in vitro , thus reducing the availability
of D.P.H". required for the oxidative decarboxylation of pyruvate to acetyl-CoA.
(Yielding, Tomlcins & Munday,I960.)
It is difficult to find an explanation for the observations of
those workers who have found normal blood pyruvate concentrations in
Cushing's Syndrome. Ho one has estimated the concentrations repaatedly in
individual patients with Cushing's Syndrome; this would probably be worth
doing, since Prunty(l960) has pointed out that the Cortisol production
rate in these patients is extremely labile, varying greatly over short
periods of time. Thus the raised Cortisol production rate measured in
these cases can only be regarded as an indication of the hyperactivity
on the day when the blood keto—acid concentration was measured, since
practical problems made it impossible to study both on the same day.
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An extension of the study of the keto-acids in the "blood of
patients with Cushin^s Syndrome and with Addison's Disease would "be
worthwhile, in order to define with some certainty the level of "branch-
chain keto—acids , particularly in the latter disease; an extensive
review of the literature suggests that this study has not "been undertaken,
pro"ba"bly "because of the relative infrequency with which Cushing's Syndrome
presents, and the rarity of Addison's Disease.
Since Cortisol has "been shown to promote gluconeogenesis from
amino—acids, it might he assumed that the level of branch—chain ketoacids
might he raised; although G.P.T. activity has heen shown to he raised in
rat liver treated with cortisone, there is no evidence to suggest that
branch-chain amino acid transaminase activity is increased, and if the
evidence discussed above is to he accepted, the effect of Cortisol on
pyruvic oxidase would have little effect on the branch-chain ketoacids;
reference th fig.I2 shows that the end products of cataholism of these
acids are acetyl-CoA or propionyl-CoA, both of which enter the citric
acid cycle by routes which bypass pyruvate.Thus it would seem that the
branch-chain ketoacids are unlikely to be present in abnormal concentrations
in the blood of patients with hyper- or hypo- adrenocorticism.
The a-ketoglutarate concentration in these diseases has never
been found to be abnormal (Hennes, Wajchenberg,Fajans & Conn,1957j
Henneman& Bunker,1957 ).Even though "'G.P, T. activity is increased, the
explanation for the lack of effect on the peripheral blood concentration
of a-ketoglutarate may be that there is a high concentration of the
compound in liver ( Le Page, 1950; Cavalini & Frontali, 1949a )j although
great caution must be exercised in drawing conclusions about the changes
in the tissues of a compound of great physiological importance and
reactivity, when only blood concentrations have been studied.
The effect of Cortisol at the pyruvic oxidase level may
explain why those patients who develop "steroid diabetes" never develop
ketosis, since a relatively small concentration of acetyl-CoA would be
available to either enter the citric acid cycle, or to condense to form
aceto-acetic acid, or the other "ketone Tjodies"(Forsham,I96l )
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3• 2. The Ketoacids in Hepatic Disease.
1ifteen patients with hepatic disease were studied, the results
being presented in table 12. All these patients, with the exception of
D.G.,had fasted for 12 hours and rested in bed overnight.
Those concentrations outside the range of mean - 2.S.D. which
was defined in section 2.1 above are regarded as abnormal, andhave been
underlined in table 12. Thus in 11 cases the a-ketoglutarate concentration
is abnormal, and. the:'pyruvate and branch chain ketoacid concentration is
abnormal in only 2 cases each.
The abnormal pyruvate concentration in case D.G. is probably
due to the intravenous glucose infusion which the patient was administered
for some 12 hours before blood was sampled.
The finding of high concentrations of a-ketoglutaric acid confirms
the observations of many groups of workers in patients with hepatocellular
damage and in patients with cirrhosis (Seligson, 1952; Amatuzio and
Nesbitt, 1950, Summerskill, Wolfe and Davidson, 1957; Bianchessi,195S),
but an extensive review of the literature suggests that no one has
previously reported abnormal concentrations of a-ketoglutarate in the
blood of patients with obstructive jaundice; clearly some of these
patients do present an abnormal level.
From the limited survey presented here, it would seem that a
study of the blood ketoacids has no value in the differential diagnosis
of hepatocellular and obstructive jaundice.
So diverse are the many activities and so great is the
functional reserve capacity of the liver, that no single test can be






























































































































































































































































damage, and of the reserve capacity of the liver, (MacLagan, 1956; Popper
and Schaffner, 1957), although the severity of parenchymatous damage is
regarded as paralleling the rise in thymol turbidity and severe damage
may be associated with a low serum albumin (Stewart and Dunlop, 1962).
Claims have been made that the fall of esterified cholesterol in blood
is related to hepatocellular damage in cirrhosis (White, Deutsch, Haddock,
Downing, and Jensen, 1939) although it is now believed that this change
is associated more with the degree of jaundice rather than with its cause
(Zieve, 1953).
The bromsulphthalein excretion test is regarded as a sensitive
index of hepatocellular damage in non-jaundiced patients, but it is so
sensitive that significant retention of the dye has been observed in
temporary functional disturbances such as fevers, anaemias, circulatory
failure (haemorrhagic) and in rheumatoid arthritis and diabetes mellitus
(MacLagan, 1956).
The most valuable indication of active hepatocellular damage is
probably the demonstration of raised G-O.T. and G-P.T. activity in the
serum of patients with the various hepatic diseases (Wroblewski, 1956).
The brief survey above makes it clear why a "battery" of biochemical
tests are used for the assessment of liver function (MacLagan, 1956), and
it was hoped at the beginning of this study that the estimation of blood
ketoacids may assist in this task. Unfortunately there appears to be
no evidence in the values presented here that the blood ketoacid
concentration is an index of hepatocellular damage. Ihus if the serum
transaminase levels are accepted as a parameter of hepatocellular damage,
patient J.S. has much more severe damage than patient M.M. but yet the
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blood ketoacid concentrations are very similar, with equally abnormal
a-ketoglutarate concentrations in both.
Similarly, in the patients with cirrhosis, although active cirrhosis
(as indicated by an abnormally high serum transaminase activity) is
associated with a high a-ketoglutarate concentration, high levels are also
to be found in patients with inactive cirrhosis. These findings are in
accordance with the views of Popper and Schaffner (1957) consider the
blood a-ketoglutarate concentration to be "of limited diagnostic and
prognostic value."
It would appear that the abnormally high blood level of a-keto¬
glutarate in patients with hepatic disease is due to the inability of
the liver to remove and metabolise the compound efficiently. Thus the
liver takes up a-ketoglutarate and pyruvic acids, as shown by a positive
arteriovenous difference (Seligson, 1956,) and the blood a-ketoglutarate
rose to abnormally high levels in 100$ of animals subjected to porta-caval
anastomosis and ligation of the hepatic arteries (Giges, Dein, Sborov,
Seligson and Howard, 1953).
The precise biochemical lesion which occurs in diseased livers to
cause the phenomena observed above is not known. oeligson (1956) believes
that there may be some abnormality of the citric acio. c^cle, and in
addition, he states that "in the failing liver there are suggestions that
the normal reservoir of A.T.P. and other high energy phosphates has
diminished".
In support of the theory that energy turnover is impaired in
experimental and human hepatic injury, it has been shown that oxidation
of butyrate and pyruvate by mitochondria due to a specific defect in
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acetate activation. (Recant, 1956; Fischer and Recant, 1956;. If the
"depletion theory" of Seligson isjcorrect, then it is surprising that
only one case with cirrhosis in this series presents any abnormality in
the bianch chain ketoacid concentration in blood, for the catabolism of
bhese compounds is aependent upon an adequate supply of coenzyme A, and
thus indirectly upon an adequate supply of A.T.P.
Although the theory of Seligson is applicable to toxic and viral
hepatocellular disease, and also, possibly, to hepatic cirrhosis, it is
difficult to explain the impaired handling of a-ketoglutarate in early
obstructive jaundice, where the hepatic cells were, presumably, normal
before the onset of the disease. Perhaps, however, the explanation is
provided by Zetterstrom and Ernster (1956) who showed, that unconjugated
bilirubin in a concentration of 20 mg/100 ml. caused uncoupling of
oxidative phosphorylation by rat liver mitochondria, though conjugated
bilirubin did not possess this effect.
Although this concentration of bilirubin is large and the total
blood concentration of bilirubin, in both its conjugated and unconjugated
form, is rarely higher than this value in obstructive jaundice, it has
been shown that the concentration of both types of bilirubin is raised
in the blood of patients with obstructive jaundice (Billing, 1959)f thus
it is quite likely that the local concentration of the pigment within and
around the hepatic cells reaches the critical level found by Zetterstrom
and Ernster. Although no quantitative estimate appears to be available
for the bilirubin content in the liver of patients with obstructive jaundice,
the pigmentation of that organ at post mortem is striking.
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3- 3. Diabetes mellitus.
Five patients with insulin-requiring diabetes mellitus of moderate
severity were studied; blood samples were taken in the early morning,
after casting overnight, and at a time when the patient was thought to be
free of the effect of exogenous insulin (all were under investigation of
their diabetic state, and were on a therapeutic regime of short acting
insulins), and free of ketosis.
The results obtained are presented in table 13, where it will be
seen that no abnormal ketoacid concentrations were found. The finding
of normal blood concentrations of a-ketoglutaric and pyruvic acids is
in accordance with the experience of most recent authors, although there
was some earlier conflict, reviewed in part I of this thesis.
Although much work has been done on and published about the
concentration of pyruvic and a-ketoglutaric acids in the blood of
diabetics, there appear to have been none about the branch chain ketoacid
concentrations.
The large volume by Williams (i960) testifies to the complexity of
the aetiology and pathogenesis of diabetic mellitus, and it would be
foolish to regard the syndrome as being purely due to deficiency of
insulin secretion by the pancreas, although many of the metabolic
abnormalities (e.g. nitrogen loss) may be reversed by the administration
of exogenous insulin. Because of the dramatic therapeutic value of
insulin in an otherwise fatal disease, it is perhaps natural that more
work has been done on the metabolic effects of insulin, than on other
aspects of the chemical pathology of diabetes mellitus.
The intimate effect of insulin on the metabolism of aminoacids,
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is obscure, but it appears that the promotion of protein synthesis by
the hoimono is an indirect effect, via the stimulus to glucose metabolism,
tnus increasing the amount of energy necessary for the endergonic
synthesis of protein. (See Fruton and Simmonds, 1958).
Certainly there appears to be no evidence that the presence or
absence of insulin promotes the catabolism of aminoacids, and the author
reels that it is not surprising that the branch chain ketoacid
concentration in the blood of the patients studied here, is within the
normal range. The intimate mechanism of the effect of insulin on
carbohydrate metabolism is still not clear, and it is not proposed to
discuss it here, the reader being referred to the volume edited by
Williams (i960), where an exhaustive review of the problem is presented.
The effect of the hormone in so far as it effects a-ketoglutaric acid and
pyruvic acid has been discussed in part I.
Table 13. The blood ketoacid concentration in
5 patients with diabetes mellitus.
Patient Age Insulin requirements Blood ketoacid concn. jig/100 ml.
units/day. a-KG P Br. chain
(as KMV)
M.S. 23 AO 78 495 580
T.E. 32 32 107 528 420
M.H. 41 18 115 603 525
H.S. 29 46 89 508 654
P.E. 29 38 95 627 398
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3» 4- • The Ketoacids and Intestinal Absorption.
During the course of a study of the serum aminoacids of normal
subjects and cases of "malabsorption syndrome" after the ingestion of
pure casein, it was noted that the serum glutamic acid concentration did
not rise, although that of other aminoacids did (Richmond and Girdwood,
I960). This phenomenon was rather puzzling, since casein contains
22.5 g. of glutamic acid per 100 g. protein (Fieser and Fieser, 1950),
and the conclusion was to be drawn that glutamic acid was not absorbed,
or that it was converted to some other compound. Dent and Schilling
(1949) obtained experimental evidence for the absorption of L-glutamic
acid in animals, and it was concluded that the glutamic acid must be
converted to some other compound. Since L-glutamic acid is a highly
important and active substrate of transaminase systems (see Part I) it
was thought that the L-glutamic acid might be converted to a-ketoglutaric
acid.
Thus it was decided to study the ketoacid concentration in the
venous blood of patients to whom protein was given orally.
In the preliminary studies in this field, fasting, resting patients
were given 25 g. of pure casein ("Casilan", Glaxo Laboratories Ltd.)
suspended in 50 ml. of water, and blood samples taken at intervals
thereafter. Each blood sample was analysed by the method described here
for ketoacids, whilst serum aminoacids were assayed microbiologically
using the organism Lactobacillus mesenteroides. Previous work in this
field by Richmond and Girdwood (I960) had suggested that the arbitrary
selection of sample timing at 0 (fasting), 0.5, 1, 2, 3 and U hours was
satisfactory, and therefore these intervals were used here.
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Table 14 shows the preliminary results which were obtained in one
control and four patients with disease; the maximum level attained in
the case of each ketoacid is underlined, where a rise was shown.
Unfortunately the pattern of response showed a complete lack of
uniformity, and it is impossible to apply any statistical test of
significance to them. When, however, the results were viewed against
the background of normal, fasting subjects which was presented in section
1.3 above, it was felt that a rise in the concentration of ketoacids had
occurred in some cases. Thus control M.H. showed substantial rise in
all three groups of ketoacids, although the response in the other cases
was small or non-existent. Subject J.R. is of particular interest
since no rise in a-ketoglutarate occurred on the occasion of the first
test, there was a rise when the test was repeated 3 days later; at the
blood concentration exhibited by this patient, the experimental error was
taken as - 5%, and the very small rise presented in the first experiment
may have been due purely to experimental error, whilst in the second
experiment, the rise was greater than could be attributed to experimental
error.
In the case of other ketoacids and of other patients, those rises
in concentration greater than could be attributed to experimental error
are underlined.
In view of the variable nature of the response described in
table 14, it was decided to avoid the enzymic digestion of protein to
aminoacids which occurs before absorption, in order to eliminate a
possible source of an additional experimental variable. Accordingly,
















































































































































3.52 3.48 3.60 3.41 3.38 3.52
Leucine 1.46 4.61 5.17 4.87 3.15 2.65
Phenyl-






































































































































alamine J :1 • 09 1.92 2.87 1.92 1.54 1.39
Keto-acids pg/l0^ ^^ /,a°^
121.
a further series of patients to whom pure L-glutamic acid was given
were studied.
In order to maintain the "load" of glutamic acid within physiological
limits, the patients were given 10 g. of the compound (equivalent to
the quantity contained in approximately 50 g. of casein); the pure, free
L-glutamic acid was suspended in 50 ml. water and given to the subject.
Other conditions were like those of the "Casilan" series. Seven control
subjects and three with "Malabsorption Syndrome" were studied, the
results being presented in table 15. Again those rises in concentration
which are greater than can be attributed to experimental error are
underlined. It will be seen that the results are once more disappoint¬
ing, for only three of the six controls and one of the three patients
showed a rise in a-ketoglutaric acid concentration.
Little work on this problem of the relationship between
administered glutamic acid and the blood a-ketoglutarate concentration
appears to have been undertaken, although Seitz, Englhardt-Golkel and
Schaffry (l958)reported some figures.
Seitz, Englhardt-Golkel and Schaffry report having found
similarly inconsistent responses in normal subjects whose blood a-keto¬
glutarate concentration was measured enzymatically. Because of this
variable response, interpretation of the observations presented here is
difficult, although some experiments by others on experimental animals
may assist in the task.
In 1949 Dent and Schilling studied the concentration of amino acids
in the portal blood after ingestion of casein, and found a glutamic acid
concentration lower than would be predicted from its high concentration
ijb&L i
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in casein. Wiseman (1953) found that glutamic acid disappeared from the
system he used for the study of its absorption by rat small intestine
iS Ziiro* Neame and Wiseman (1957,1958) found that the concentration
of alanine in the mesenteric venous blood from a loop of small bowel
containing glutamic acid was greater than that in arterial blood (dogs,
cats and rabbits). This finding they regard as indicating that
transamination of glutamic acid in the glutamic-pyruvic transaminase
reaction, although they failed to find any change in the concentration
of a-ketoglutaric and pyruvic acids after the blood had passed through
the gut. Thus there is incomplete evidence that transamination occurs
in the intestine of experimental animals, and this observation may
explain the apparent failure to demonstrate a raised L-glutamic acid
concentration in the peripheral venous blood of human subjects, if
transamination occurs in the human small bowel. Unfortunately the portal
blood must pass through the liver, the site of very active transaminase
activity (Wroblewski, 1958) so that any L-glutamic acid in the portal
blood would be rapidly transaminated and the resulting a-ketoglutaric
acid rapidly metabolised by the liver. Thus any rise in the venous
blood concentration of either L-glutamic acid or of a—ketoglutaric acid
would probably be small, reflecting a "spill over" of these compounds
when the load exceeded the reserve capacity of the liver to metabolise
the compounds, and also dilution of the added compounds in the already
existing "body poM" of them.
The results presented hare are relatively few and are regarded
merely as an indicator of a problem whose solution is still required.
It has been proposed to alter the design of the experiment and to use
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further techniques to attempt the elucidation of the problem (Richmond,
Girdwood and Smith, 1961). The use of the sodium salt of L-glutamic
acid instead of the actual free acid may be regarded as being a more
sensible step, but early experience in this series of experiments
suggested that human subjects found it extremely difficult to tolerate
and tenoed to vomit the compound} perhaps the use of gastric intubation
may avoid some of this effect, although Seitz, Englhardt-Golkel and
Schaffry,(1958) found equally inconsistent results when administering
25 g. of the sodium salt.
The use of a chromatographic method of estimating the aminoacids
rather than a microbiological method is regarded as more accurate
(Fruton and Simmonds, 1958), and in this particular series the micro¬
biological method has proved unsatisfactory, particularly since it
failed to assay alanine, the product noted by Neame and Wiseman (1957)
in their in vitro and in vivo experiments.
Finally the possibility of using C1^ labelled glutamic acid to
study the absorption and metabolism of the compound has been discussed
(Richmond, Girdwood and Smith, 1961).
Since, however, this last proposal will probably necessitate animal
experiment first in order to study the amount of radioactivity retained
in the body and the necessary "dose® to give, the project has become




The studies presented in this thesis demonstrate the
diverse pathological conditions in which the keto-acids are of interest,
because of their biological importance as highly active metabolic
intermediates.
In addition,the inadequacy of available methods is
demonstrated; as yet there is no method suitable for the separation
and estimation of all known keto-acids,although a step forward has
recently been made by Kaser,Kaser & Lestradet(l96o),who managed to
separate KIV—hydrazone from those of KIC and KMV.The demonstration
of the presence of the "branch chain" keto-acids" by he Schepper,et al
in 1958,caused "an impetus to the waning interest in keto-acids"(Smith,i960).
Even though methods available are imperfect,the discovery of
these compounds hass"opened a new door"into the study of inborn
errors of metabolism,with the description of "Maple Syrup disease",
which was discussed in Part I.Mo doubt methods will be devised for
the separation of the "branch chain" keto-acids which remain,as yet,
unseparated,thus providing a useful means of studying the intermediary
metabolism of tjie corresponding amino acids.
There seems to be no doubt that more keto-acids will
be identified in material from human subjects.Thus,Biserte and
Dassonville(l956) ,and McArdle(l957) have noted small traces of a
hydrazone with low Rf value,but of unknown nature,and infrequent
appearance,in urine. The present author has also/oted occasionally
a small, intensely yellow,ultra-violet opaque spot which travels
immediately in front of the a—KG hydrazone on chromatograms prepared
from the extracts of concentrated urine. The quantity of the unknown
was so small that attempts to elute it and examine its absorption
spectrum in MaOH failed,and the present author does not know its
nature,but he feels that it may be a dicarboxylic acid,because of
its low Rf.
The tedious,prolonged nature of paper chromatographic
methods is an additional limitation in the study of clinical problems,
and the introduction of a full range of rapid,specific methods
comparable to the enzymatic methods available for the estimation
of a-ketoglutaric acid and pyruvic acid,would be of great help.
A good deal of information is being obtained about the
role of a-ketoglutarate and pyruvate in various clinical conditions,
by the application of these enzymatic methods,notably by Marks(l96l)
and his colleagues, but the knowledge of the'role of the "branch
chain" compounds is in a most rudimentary form.
Unfortunately the clinical chemist must work with limitations
not shared by his academic biochemical colleague;thus the former
has only a relatively few sources of material to analyse. In the
work described above in section 3.4, the aim had been to attempt
to demonstrate the deamination of glutamic acid,during,or immediately
after absorption,but the only material available for analysis was
peripheral venous blood,the concentration of a—KG in which reflects
the possible activity of the gut mucosa upon the absorbed glutamic
acid,but also reflects the much greater activity of the liver.
Thus a measurement of the keto-acid content of the portal blood
would have been of great help in defining the transaminase activity
of the gut towards glutamic acid,much in the same way as Neame and
¥iseman(l957 &I958 ) studied the phenomenon in experimental
animals. Attempts were made to study the portal vein keto-acids
in blood obtained at laparotomy,but it soom became evident that
this proceedure such that it was not possible to control the conditions
under which the samples were collected. Further,a surgeon worried
about the technical problems of his craft cannot be distracted at
intervals to collect blood.
In common with many other workers,the study of keto-acids
in disease presented here is rather superficial,and the author feels
that much more information may be obtained by undertaking a detailed
study of a few cases, with a simultaneous study of the other
parameters relative to the particular disease. Thus the mystery of
why some patients with Cushing's Syndrome present a high fasting
blood pyruvate concentrations,whilst others do not,remains a m
unsolved,and perhaps an extended study on the lines presented in
Section 3.1 above,with estimations related to the natural history
and course of the disease,would contribute to its solution. This
example,however,underlines another problem of the clinical chemist:
that of obtaining a source of suitable patients,for most do not
come under medical care until their disease is well developed,and
many require urgent therapy because of the serious prognosis
of their illness,as in this particular example(¥illiams,I96l).
(
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From the few detailed, studies on normal subjects presented in
this work,it is evident that considerable daily,and even hourly,
variation in the blood concentration of the keto—acids occurs. The
author feels that an extension of this type of study,both in normal
subjects and patients with various diseases may reveal further interesting
information,in the same way that detailed studies e revealed the
loss of normal diurnal adrenal activity in (lushing's Syndrome
(Forsham,I96I;Prunty,1960) This type of project,however,requires
circumstances in which it is possible to supervise patients closely,
and which the clinical chemist can seldom achieve.Further,it rquires
patients with sufficient courage to withstand multiple venepunctures.
On the basis of this and other studies undertaken by
many workers,the diagnostic and prognostic value of blood concentrations
of the keto-acids appears to be strictly limited,although the author
feels that it will be necessary to undertake much more work,both
on devising suitable methods and on the study of disease,before this
impression is confirmed. The value of blood keto-acid concentrations
in the past,appears to have been the way in which they have reflected
changes in intermediary metabolism caused by some "biochemical
lesions", (e. g. the demonstration of a raised concentration of
pyruvic acid in the blood of beri-beri patients.) The recent discovery
of "branch chain" keto-acids in blood has opened up a new field
in which,already, a measurement of these compounds in both blood
and urine has indicated the presence of a defect in the metabolism
of amino acids in "Maple Syrup Disease."
Perhaps the most significant indication that much
remains to be done lies in the words of De Schepper,Parmentier and
Van der Saeghe(l958):that "the total 'branch chain' keto-acid
concentration in the blood was found to be abnormal in certain diseases"
(sic);the failure of the work described in this thesis to demonstrate
a disease in which such an abnormality is found consistently






Statistical formulae used, and, their application.
The notations used here are those of Bernstein and Weatherall
(1952).
I. The calculation of Standard Deviation.
Let S signify "the sum of like terms"
n he the number of observations,x^jx^x^, x
then the mean of n terms is given by :
x - S(x)
n Equation i
The standard deviation(S.D.) IS calculated from the formula
S.D.s jJ S(x-x) 2 , where n is less than 30 Eqn. 2
n -I
— 2
S(x - x) was computed from the convenient expression:
S(x -x)^ = S(x^) - (Sx)^
n Equation 3
2.The effect of concentration on reproducibility.
For each "lot" of 4 samples from the same serum source,the mean
and S.D. were calculated. The S.D. was then treated as the dependent
variable ("y") with the lot mean
the independent variable("x":)'0where
the two are treated graphically as
ordinate and abscissa,respectively.
If a straight line is drawn through
a point with co-ordinates x,y,and
in such a way that the sum of the
squares of the deviations of
individual values of y from the
value , Y(, that predicted from a
knowledge of the equation of






X Lof £ac.H i~otJ
Fig.29 The regression line.
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the line may "be called the .fficient of regression"'jgiven by the
equation:
13 — S(^Y -xy)
^(x -x) Equation 4
S(xy — xy) is calculated from the equation:
S(xy - xy) = S(xy) - S(x).S(y)
n Equation 5
Standard Error of regression coefficient.
The sum of squares of deviations of values of y from the
predicted value,Y, is given "by
s(y - Y)2 s= S(y - y)2 - "b. S(xy - xy)
therefore the variance of this value
s2^ S(y - Y)2 __ S(y -Y)2
]q — 2
number of degrees of freedom n - 2
The statistical significance of the regression coefficient.
The t value is obtained:
t = b
S.E. of b
With the value of t thus obtained,and n -2 degrees of freedom,then
reference to the tables of Fisher and Yates(l948) makes it possible to
define the probability of b being different from zero.
It is hoped that the above discussion will be clearer
after the relevant figures have been calculated for the keto-acids,below.
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Since all samples of serum were treated similarly,the results presented
"below are the optical densities of the final eluates,each multiplied
"by 10 ,"but the lowest and highest values are converted to concentrations
in the relevant samples of serum^and were reported in Part 2 above.
a) Pyruvic acid.
Each figure "below is the sum of the individual values for
the two isomeric spots,Pj andP^.
"Lot'
Samole A B C D E P
I 431 350 521 608 844 550
2 426 329 489 582 879 552
3 429 318 510 668 797 612
4 435 353 582 651 775 618
439.25 337. 50 525. 50 627.25 823.75 583.00 Lot means("x")




S(x2)=3,987 ,067.1875 (Sx) 2s1,845,098.7604 S(x - x) = 141,968.4271
n
2
S(y2)s6 ,998.6177 (Sy)j5,627. 3438 S(y - y) = 1,371.2739
n
S(xy)=II3,058.7200~J3xJ3y_=I0I,897.03I S(xy xy)~II,l6l.
3= S(xy - xy) = 0.078621
S(x - x)2
h.S(xy - xy) = 877.5423
S(y - Y)2^ 1,371.2739 - 877. 5423 =493.7316.





__ 493,7316 = 493.7316 - 123.4329.
n - 2 4
-+O.O29486.
130.
* = °-°786 2.664.
O.0295




Sample A B C I) E P
I 153 126 248 202 I89 428
2 155 132 252 208 198 398
3 148 134 254 196 208 429
4 149 134 248 193 205 422
151.25 131.50 250.50 199.75 200.00 419.25 Lot means ("x"
3.30 3.79 3.00 6.65 8.45 14.49 S.D. for each
Lot ("y")
n = 6
S(x) «1,352.25 S(y) =39-68
S(x2) =358,589.6875 (Sx}_2= 304,763.3875 S(x - x) 2 - 53,826.3000
n
S(y2) =359.7392 (Sy)2= 262.4171 S(y-y)2= 97.3221
n
S(xy) =10,842.28 Sx.Sy ^ 8,942.88 S(xy - £y)=I,899-4000
n
h = 0.0443875.
h.S(xy - xy) = 84.3096175
S(y - T)\ = 13.0125-
s2 ^ 3.253125
S.E. of bs / 3.253125 = - 0-00T77
aJ 53,826.3000
t —0,04439 = 5.71. With 4 degrees of freedom, F <0.01
0.00777
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c) Branch chain keto-acids.
Sample
»•
A B C D
I 389 443 301 473
2 362 415 326 451
3 401 432 330 437
4 390 451 315 461
385. 50 435.25 318.00 455.50 Lot means (*x")
17.58 15.59 12.99 14.25 S.D. of each lot
n = 4
S(x) =35594.25 S(y) = 60.4I
S(x2)=646,657.0625 (Sx) =635,408.2656 S(x - x)2= 11,248.7969
n
S(y2) =• 919.2925 fgy)2—912.342 S(y - y)2= 6.9505
n
S(xy)«- 24,255.7075 Sx^_ = 24,077.1606 S(xy - xy)' = 178. 5469
n
h,- 178.5462_ = 0.0158725.
11,248.7969
Id. S(xy -xy) = 2.83399
S(y - T)2 =: 6.9505 -2.83399 ~ 4.H64
s2 _ 4.H64 = 2.0582.
"
n - 2
S.E. of "b = /2.0582 = ~ 0-01353
7 11,248.7969
„ /-.-rronnc - I.II7574- With 2 degrees of freedom,






The formulae used to calculate Concentrations in Biological Fluids.
O.D. — Optical density of NaOH extract from
chromatogram,against corresponding "blank.
X ;= Concentration of hydrazone in the NaOH extract
(mg. /lOOml.)
m := Gradient of line of established calibration
curve.
A - Volume of blood,urine,or serum taken.
B - Total volume of blood,urine,or serum plus
precipitant.
C -s Volume of protein free supernatant taken to
react -with 2,4-DNPH.
D - Vol. of ammoniacal extract applied to the
chromatography paper.
E c Vol. NaOH used to elute the individual spots.
Since the straight line of the calibration graphs pass through
the origin,the equation for the line is:
0. D."= m.X. ,
therefore X = O.D. Equation I.
but E ml.NaOH were used to elute the spot,therefore the total
quantity of hydrazone present in the alkaline solution is:
0.D.y ®
m 100.
This quantity was obtained from D ml. of ammoniacal solution,and
therefore the quantity of hydrazone present in 1.0 ml. ammoniacal
solution is : O.D^ E ^1
m 100 D.
q^g^tity represents the keto acids obtained from an aliquot,C,
of the total B ml. of deproteinised solution.
Therefore the total quantity of keto-acid obtained from the source
is: O.D... E „ I v B (AS THE HYDRAZONE)
"^IO^D* C
And the volume of the original source (blood, serum,or urine ) was A ml.
therefore the concentration in the original source is:
0 D E I B 100 mg. hydrazone/lOOml Equation 2.
' i 3
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Before the formula derived, in equation 2 can he applied,however,
it is necessary to apply corrections:
1. To obtain the concentration in terms of the free acid,the above
expression must be multiplied by the factor:
Mol.Wt. of free acid.
Mol.Wt. of hydrazone.
2. Corrections for losses during extraction and chromatography must
be applied.The corrections,based upon estimates obtained in Part I,
are presented in tabular form below.
Mol.Wt.
Keto—acid. Value of "m" Correction for Correction for
O.D.units/mg. free acid. losses.
a-KG. 0.52 146 100
328 75
Pyruv. 0.77 88 100
270 70
KMV. 0.60 130 100
In calculating the concentration of any keto-acid,the
relevant value for "m" is inserted in equation,^, and the formula
thus obtained multiplied by the corrections for recovery and
for the conversion to "free" keto-acid.
The formula derived in equation 2 is satisfactory for
application to circumstances where the quantities of blood,serum
or urine are measured by voluE%but,as has been seen above,in many
estimations these quantities were measured by weight,and a small
correction must be applied :
the specific gravity of blood is taken as 1.060 (Marks,I96j ).
Let b -weight of blood,in gm.
and T = weight of blood plus precipitant.
Then the volume of blood is: b
1^60
and the volume of blood plus precipitant is:
(T - b)-t- b
1.060
thus,substituting,equation 2 becomes:
concentration — O.D.y /l.060T -0.0o0b_
m 100 PC b
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This correction produces final blood concentrations approximately
5$ higher than those obtained by using equation 2,and ignoring
the slight error due to the differing S.G. values of blood and
water.
An equation similar to that in equation 2 was derived
by he Schepper,Parmentier and Van der Haeghe(l958o)
The production rate of urinary keto-acids.
PrQduction rates of the urinary keto-acids were calculated by
multiplying equation 2 by the factor:
Volume o/n urine
^ 1
100 Time of collection(hr.)
after the equation was corrected for recovery and for conversion
of the result to the "free" acid.
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